Processing 00000000.tx.1: Blood-Brain Barrier Damage Induces Release of 2-Macroglobulin* Luca Cucullo, Nicola Marchi, Matteo Marroni, Vincent Fazio, Shobu Namura and Damir Janigro,, Department of Neurological Surgery, Cerebrovascular Research Center, Cleveland Clinic Foundation, Cleveland, Ohio 44195 Department of Cell Biology, Cerebrovascular Research Center, Cleveland Clinic Foundation, Cleveland, Ohio 44195  ABSTRACT TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Blood-brain barrier (BBB) failure occurs in many neurological diseases and is caused in part by activation of proinflammatory factors including matrix metalloproteinases. 

Phrase: "Blood-Brain Barrier Damage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0270611:Brain damage [Injury or Poisoning]
   812   C0010957:Damage [Injury or Poisoning]
   812   C1883709:Damage [Functional Concept]
   756   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
   756   C1305865:Blood-brain barrier [Organ or Tissue Function]

Phrase: "Induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Release of 2-Macroglobulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "* Luca Cucullo,"

Phrase: "Nicola Marchi,"

Phrase: "Matteo Marroni,"

Phrase: "Vincent Fazio,"

Phrase: "Shobu Namura"

Phrase: "and"

Phrase: "Damir Janigro,"

Phrase: ", Department of Neurological Surgery,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Cerebrovascular Research Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0683939:research center [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "Cleveland Clinic Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio 44195 Department of Cell Biology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "Cerebrovascular Research Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0683939:research center [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "Cleveland Clinic Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio 44195  ABSTRACT TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "(BBB) failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "occurs in many neurological diseases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0027765:neurological disease [Disease or Syndrome]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C0205494:Neurological [Qualitative Concept]
   760   C1709305:Occur [Activity]
   760   C2707261:Neurological [Clinical Attribute]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "is"

Phrase: "caused in part"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "by activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of proinflammatory factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "matrix metalloproteinases."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]
Processing 00000000.tx.2: Counterbalancing, "BBB protective" cascades have recently been described, including NO-mediated interleukin 6 release by glia. 

Phrase: "Counterbalancing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707527:Counterbalance [Manufactured Object]

Phrase: """BBB protective"" cascades"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1707310:Cascade [Manufactured Object]

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "NO-mediated interleukin 6 release by glia."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0021760:Interleukin-6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C1527132:interleukin 6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.3: Interleukin 6 has been shown to trigger production of matrix metalloproteinase inhibitors such as 2-macroglobulin (2M). 

Phrase: "Interleukin 6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021760:Interleukin-6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1527132:interleukin 6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "production of matrix metalloproteinase inhibitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "such as 2-macroglobulin (2M)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.4: We hypothesized that BBB failure may result in increased 2M release by perivascular astrocytes. 

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that BBB failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "may"

Phrase: "result in increased 2M release"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0030685:Release [Health Care Activity]
   753   C0205217:Increased [Quantitative Concept]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0680255:release [Health Care Activity]
   753   C1274040:Result [Functional Concept]
   753   C1283071:Release [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
   753   C2825142:Result [Finding]

Phrase: "by perivascular astrocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]
Processing 00000000.tx.5: This was initially tested in patients undergoing iatrogenic BBB disruption by hyperosmotic mannitol for intra-arterial chemotherapy of brain tumors. 

Phrase: "This"

Phrase: "was"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "tested in patients"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0392366:tested [Intellectual Product]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "undergoing"

Phrase: "iatrogenic BBB disruption by hyperosmotic mannitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332453:Disruption [Functional Concept]

Phrase: "for intra-arterial chemotherapy"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0694634:Intra-arterial [Spatial Concept]
   827   C0003842:Arterial [Body Part, Organ, or Organ Component]
   827   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   827   C0013217:chemotherapy [Functional Concept]
   827   C0221464:Arterial [Spatial Concept]
   827   C0347985:Intra [Temporal Concept]
   827   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]

Phrase: "of brain tumors."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0006118:Brain Tumors [Neoplastic Process]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0027651:Tumors [Neoplastic Process]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]
Processing 00000000.tx.6: Serum samples revealed significantly increased levels of 2M at 4 h after BBB disruption by hyperosmotic mannitol. 

Phrase: "Serum samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444266:Serum sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "significantly increased levels of 2M"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0456948:Level 2 [Intellectual Product]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "at 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "after BBB disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332453:Disruption [Functional Concept]

Phrase: "by hyperosmotic mannitol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.7: In parallel in vitro experiments, we observed a similar increase of 2M release by astrocytes under conditions mimicking BBB failure and perivascular edema. 

Phrase: "In parallel in vitro experiments,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   875   C0021135:In Vitro [Intellectual Product]
   875   C1533691:in vitro [Qualitative Concept]
           vitro
   875   C2827718:In Vitro [Functional Concept]
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a similar increase of 2M release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "by astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "mimicking"

Phrase: "BBB failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "and"

Phrase: "perivascular edema."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013604:Edema [Pathologic Function]
   861   C1717255:Edema [Clinical Attribute]
Processing 00000000.tx.8: For both experiments, protein analysis was initially performed by bidimensional gel electrophoresis and mass spectrometry followed by Western blotting immunodetection. 

Phrase: "For both experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "protein analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1514534:Protein Analysis [Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "performed by bidimensional gel electrophoresis"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   806   C1550369:Performed By [Qualitative Concept]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0884358:Performed [Functional Concept]
   760   C1382104:Gel [Substance]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "followed by Western blotting immunodetection."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0332283:Followed by [Temporal Concept]
           followed
   790 E C0949466:Western Blot [Laboratory Procedure]
   760   C1705493:Western [Spatial Concept]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.9: We conclude that, in addition to proinflammatory changes, BBB failure may also trigger protective release of 2M by perivascular astrocytes as well as peripheral source. 

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that,"

Phrase: "in addition to proinflammatory changes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "BBB failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "may"

Phrase: "also"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "protective release of 2M"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "by perivascular astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "as well as"

Phrase: "peripheral source."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449416:Source [Finding]
   861   C1705919:Source [Idea or Concept]
Processing 00000000.tx.10: The mature extracellular matrix, a heterogeneous substance produced at the BBB1 level by perivascular astrocytes, serves as a tissue skeleton, as a medium of communication between cells, and as a barrier between the cells and the vascular system (1, 2). 

Phrase: "The mature extracellular matrix,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0015350:Extracellular Matrix [Tissue]
   827   C0521119:Extracellular [Cell Component]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "a heterogeneous substance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439861:Substance [Substance]

Phrase: "produced at the BBB1 level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "by perivascular astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "serves as a tissue skeleton,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0037253:Skeleton [Body System]
   760   C0040300:Tissue [Tissue]
   760   C0816871:Skeleton [Body System]
   760   C1283922:Skeleton [Body System]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "as"

Phrase: "a medium of communication"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "between cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and as a barrier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515981:And [Idea or Concept]
   770   C1706912:BARRIER [Medical Device]

Phrase: "between the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the vascular system"
Meta Candidates (Total=16; Excluded=9; Pruned=0; Remaining=7)
  1000   C0489903:Vascular System [Body System]
   944 E C0242201:Hemic System [Body System]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1558950:VASCULAR [Finding]
   861   C1704459:System [Medical Device]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   789 E C0205373:Systemic [Functional Concept]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.11: MMPs are the key components of the system that dynamically control and continuously remodel the mature extracellular matrix in living tissues. 

Phrase: "MMPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0623362:MMPs [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C0919336:MMP [Gene or Genome]

Phrase: "are"

Phrase: "the key components of the system"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "that dynamically"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "continuously"

Phrase: "remodel"

Phrase: "the mature extracellular matrix in living tissues."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0015350:Extracellular Matrix [Tissue]
   748   C0521119:Extracellular [Cell Component]
   748   C1704640:Matrix [Spatial Concept]
   748   C1706515:Matrix [Body Substance]
Processing 00000000.tx.12: The proteolytic activity of MMPs acts as an effector mechanism of tissue remodeling under physiologic and pathologic conditions and as a modulator of inflammation. 

Phrase: "The proteolytic activity of MMPs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0597304:Proteolytic [Molecular Function]
   760   C1561536:*Activity [Idea or Concept]
   760   C1947941:proteolytic [Enzyme]

Phrase: "acts as an effector mechanism of tissue remodeling"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1820201:tissue remodeling [Biologic Function]
   744   C0040300:Tissue [Tissue]
   744   C0079613:ACT [Therapeutic or Preventive Procedure]
   744   C0441712:Mechanism [Functional Concept]
   744   C1547928:Tissue [Intellectual Product]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "under physiologic"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiologic [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "pathologic conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and as a modulator of inflammation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0021368:Inflammation [Pathologic Function]
   753   C1515981:And [Idea or Concept]
   753   C1709060:Modulator [Manufactured Object]
Processing 00000000.tx.13: In the context of neuroinflammatory diseases, MMPs have been implicated in processes such as BBB failure, invasion of neural tissue by blood-derived immune cells, and cellular damage in diseases of the central nervous system (1, 3, 4). 

Phrase: "In the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of neuroinflammatory diseases,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "MMPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0623362:MMPs [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C0919336:MMP [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1184743:Process [Body Part, Organ, or Organ Component]
   756   C1522240:Process [Phenomenon or Process]

Phrase: "such as BBB failure,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "invasion of neural tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1269955:Invasion [Finding]
   770   C2699153:Invasion [Pathologic Function]

Phrase: "by blood-derived immune cells,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   902   C0005773:Blood Cells [Cell]
   858 E C2328697:Hemal cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cellular damage in diseases of the central nervous system"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0010957:Damage [Injury or Poisoning]
   742   C1883709:Damage [Functional Concept]
   729   C0751792:Neurological Damage [Injury or Poisoning]
   716   C0007682:Diseases of the central nervous system [Disease or Syndrome]
   704   C0161479:Nerve damage [Injury or Poisoning]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.14: In the central nervous system, matrix remodeling by metalloproteinases gelatinase A (MMP-2) and gelatinase B (MMP-9) play a major role in maintaining BBB integrity (57). 

Phrase: "In the central nervous system,"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "matrix remodeling by metalloproteinases gelatinase A (MMP-2"

Phrase: ")"

Phrase: "and"

Phrase: "gelatinase B (MMP-9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1334523:MMP9 [Gene or Genome]
   861   C2698028:MMP9 [Laboratory Procedure]
   812   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0919336:MMP [Gene or Genome]

Phrase: ")"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a major role in maintaining BBB integrity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.15: Activation of proinflammatory factors and altered processes of extracellular proteolysis may contribute to the progression of tissue damage and matrix destruction leading to BBB failure after brain injury (8, 9). 

Phrase: "Activation of proinflammatory factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "altered processes of extracellular proteolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "may"

Phrase: "contribute to the progression of tissue damage"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0010957:Tissue damage [Injury or Poisoning]
           Damage
   748   C0040300:Tissue [Tissue]
   748   C0242656:progression [Pathologic Function]
   748   C0449258:Progression [Functional Concept]
   748   C1547928:Tissue [Intellectual Product]
   748   C1880177:Contribute [Activity]
   748   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "matrix destruction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1261381:Destruction [Therapeutic or Preventive Procedure]
   861   C1948029:Destruction [Activity]

Phrase: "leading to BBB failure"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0005854:BBB [Body Part, Organ, or Organ Component]
   770   C0231174:Failure [Functional Concept]
   770   C0332152:Leading [Temporal Concept]
   770   C0680095:failure [Individual Behavior]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "after brain injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0270611:Brain Injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.16: MMPs have also been implicated in the pathogenesis of neurodegenerative diseases (Alzheimers disease) and are believed to be critical events leading to BBB failure with secondary vasogenic edema and hemorrhagic transformation of infarcted brain tissue (1012). 

Phrase: "MMPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0623362:MMPs [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C0919336:MMP [Gene or Genome]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "implicated in the pathogenesis of neurodegenerative diseases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]

Phrase: "(Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "are"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "critical events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "leading to BBB failure"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0005854:BBB [Body Part, Organ, or Organ Component]
   770   C0231174:Failure [Functional Concept]
   770   C0332152:Leading [Temporal Concept]
   770   C0680095:failure [Individual Behavior]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "with secondary vasogenic edema"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1265805:Secondary edema [Pathologic Function]
   901   C2825502:Vasogenic Edema [Finding]
   827   C0013604:Edema [Pathologic Function]
   827   C1717255:Edema [Clinical Attribute]

Phrase: "and"

Phrase: "hemorrhagic transformation of infarcted brain tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0040682:Transformation [Cell Function]
   753   C1510411:Transformation [Pathologic Function]
   753   C1705163:Transformation [Research Activity]

Phrase: "(1012"

Phrase: ")."
Processing 00000000.tx.17: However, the mechanism of activation of MMPs remains unclear. 

Phrase: "However,"

Phrase: "the mechanism of activation of MMPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "remains"

Phrase: "unclear."
Processing 00000000.tx.18: MMPs are neutralized by naturally occurring inhibitors such as 2M (13, 14) or tissue inhibitors of metalloproteinases. 

Phrase: "MMPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0623362:MMPs [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C0919336:MMP [Gene or Genome]

Phrase: "are"

Phrase: "neutralized by naturally occurring inhibitors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   726   C1709305:Occur [Activity]
   726 E C1999216:Inhibitor [Qualitative Concept]
   726   C2745955:OCCUR [Temporal Concept]

Phrase: "such as 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(13,"

Phrase: "14"

Phrase: ")"

Phrase: "or"

Phrase: "tissue inhibitors of metalloproteinases."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   991   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   991   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786   C1152589:metalloproteinase inhibitor [Molecular Function]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   737 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.19: 2M is a broad spectrum protease inhibitor naturally present in serum and interstitial fluids. 

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "a broad spectrum protease inhibitor naturally"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   840   C3536890:Protease Inhibitor [Pharmacologic Substance]
   804   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C1947941:Protease [Enzyme]
   804   C1999216:Inhibitor [Qualitative Concept]

Phrase: "present in serum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0150312:Present [Quantitative Concept]
   790   C0229671:Serum [Body Substance]
   790   C0449450:Present [Idea or Concept]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "interstitial fluids."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0162367:Interstitial Fluids [Body Substance]
   861   C0005889:Fluids [Body Substance]
   861   C0302908:fluids [Substance]
   861   C0596790:interstitial [Body Location or Region]
   861   C1521806:Fluids [Tissue]
   861   C1522203:Interstitial [Functional Concept]
   827 E C0444611:Fluid [Qualitative Concept]
   827 E C1704353:Fluid [Substance]
Processing 00000000.tx.20: 2M production can be stimulated by interleukin 6 (1517). 

Phrase: "2M production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]

Phrase: "can"

Phrase: "be"

Phrase: "stimulated by interleukin 6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0021760:Interleukin-6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C1527132:interleukin 6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(1517"

Phrase: ")."
Processing 00000000.tx.21: Recent findings suggest that glucocorticoids may stimulate 2M release and inhibit up-regulation of MMP-9 (18, 19). 

Phrase: "Recent findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that glucocorticoids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "may"

Phrase: "stimulate"

Phrase: "2M release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "up-regulation of MMP-9"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041904:Up-Regulation [Cell Function,Molecular Function]
   806   C0162493:Up-Regulation [Genetic Function]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   760   C1327622:Regulation [Biologic Function]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.22: This is consistent with the concept that glucocorticoids may act as repair agents following BBB failure and edema formation (20). 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with the concept"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that glucocorticoids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "may"

Phrase: "act as repair agents"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0043240:Repair, NOS [Organism Function]
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C0374711:Repair [Therapeutic or Preventive Procedure]
   737   C0450442:Agent [Chemical Viewed Functionally]
   737   C1254351:Agent [Pharmacologic Substance]
   737   C1521826:Agent [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "BBB failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "and"

Phrase: "edema formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.23: 2M is a tetramer of four identical 180-kDa subunits exhibiting a -cysteinyl-glutamyl-thiol ester bond and inhibits the target protease by physical entrapment. 

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "a tetramer of four identical 180-kDa subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0039686:Tetramere [Eukaryote]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "a -cysteinyl-glutamyl-thiol ester bond"

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the target protease by physical entrapment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C1947941:Protease [Enzyme]
Processing 00000000.tx.24: 2M has a peptide stretch, called the "bait region," that contains specific cleavage sites for different proteinases (21, 22). 

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "has"

Phrase: "a peptide stretch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "the ""bait region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: """"

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "specific cleavage sites for different proteinases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C0449604:Specific site [Spatial Concept]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "(21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.25: This protein also binds to a number of different growth factors and cytokines suggesting that 2M may play an additional role in cellular growth regulation (23, 24). 

Phrase: "This protein also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to a number of different growth factors"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0960756:factor A [Organic Chemical]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0220844:growth [Physiologic Function]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C1145667:Bind [Activity]
   744   C1167622:bind [Molecular Function]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1705242:Different [Qualitative Concept]
   744   C2911660:Growth [Activity]
   720   C2752783:differential growth [Organism Function]
   711   C1521761:Factor [Functional Concept]
   711   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an additional role in cellular growth regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.26: We focused on the role of astrocytes (AS) and endothelial cells (EC) in BBB maintenance by studying in vitro cell culture and serum samples obtained from patients who underwent BBBD procedures during chemotherapy treatment. 

Phrase: "We"

Phrase: "focused on the role of astrocytes (AS)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0004112:Astrocytes [Cell]
   753   C0035820:Role [Social Behavior]
   753   C0205234:Focused [Spatial Concept]
   753   C1285542:focused [Functional Concept]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "endothelial cells (EC) in BBB maintenance"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0225336:Endothelial Cells [Cell]
   781   C1516348:Cell Maintenance [Cell Function]
   760   C0007634:Cells [Cell]
   760   C0014257:Endothelial [Tissue]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "by studying in vitro cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   840   C0007585:Cell Culture [Laboratory Procedure]
   804   C0007634:Cell [Cell]
   804   C0010453:Culture [Idea or Concept]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   804   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "serum samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444266:Serum sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "obtained from patients"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "who"

Phrase: "underwent"

Phrase: "BBBD procedures during chemotherapy treatment."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   797   C0013216:chemotherapy procedures [Therapeutic or Preventive Procedure]
   797   C0237403:procedures treatment [Therapeutic or Preventive Procedure]
   760   C0025664:procedures [Intellectual Product]
   760   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C2700391:procedures [Activity]
   726 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   726 E C3274430:PROCEDURE [Health Care Activity]
   726 E C3538935:Procedure [Idea or Concept]
   726 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.27: We hypothesized that BBB impairment may result in increased 2M released by perivascular astrocytes as well as peripheral sources.  

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that BBB impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0684336:Impairment [Pathologic Function]

Phrase: "may"

Phrase: "result in increased 2M"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "released by perivascular astrocytes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0004112:Astrocytes [Cell]
   770   C0391871:Released [Functional Concept]
   770   C0442165:Perivascular [Spatial Concept]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "as well as"

Phrase: "peripheral sources."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449416:sources [Finding]
   827 E C1705919:Source [Idea or Concept]
Processing 00000000.tx.28: EXPERIMENTAL PROCEDURES TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Cell Isolation and Culture Specimens were obtained with the consent of patients undergoing brain surgery; 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell Isolation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007616:Cell Isolation [Laboratory Procedure]
   861   C0204727:Isolation [Therapeutic or Preventive Procedure]
   861   C0205409:Isolation [Functional Concept]
   861   C0220862:isolation [Laboratory Procedure]
   789 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "Culture Specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0370003:specimens [Substance]
   827 E C2347026:Specimen [Conceptual Entity]

Phrase: "were"

Phrase: "obtained with the consent of patients"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0030705:Patients [Patient or Disabled Group]
   753   C1301820:Obtained [Functional Concept]
   753   C1511481:Consent [Functional Concept]
   753   C1554192:consent [Idea or Concept]
   737   C1532670:Obtaining consent [Health Care Activity]
   719 E C1706701:Obtain [Activity]

Phrase: "undergoing"

Phrase: "brain surgery"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0195775:brain surgery [Therapeutic or Preventive Procedure]
   861   C0038894:Surgery [Biomedical Occupation or Discipline]
   861   C0038895:surgery [Functional Concept]
   861   C0543467:Surgery [Health Care Activity]

Phrase: ";"
Processing 00000000.tx.29: the details of this procedure are listed elsewhere (25, 26). 

Phrase: "the details of this procedure"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1522508:Details [Qualitative Concept]
   726 E C1561567:detail [Functional Concept]

Phrase: "are"

Phrase: "listed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0745732:List [Conceptual Entity]
   966   C3272378:LIST [Intellectual Product]

Phrase: "elsewhere"

Phrase: "(25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.30: Primary AS and primary EC were isolated from human brain tissue and co-cultured in 75-mm-diameter Transwell polycarbonate membrane with pore size of 0.4 m and total insert growth area of 44 cm2 (Costar 3419). 

Phrase: "Primary AS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "primary EC"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0225336:Endothelial Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "isolated from human brain tissue"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0440746:Brain tissue [Tissue]
   806   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   797   C0440744:Human tissue [Tissue]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0040300:Tissue [Tissue]
   760   C0086418:Human [Human]
   760   C0205409:Isolated [Functional Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1547928:Tissue [Intellectual Product]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "co-cultured in 75-mm-diameter Transwell polycarbonate membrane"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0282547:Co-culture [Laboratory Procedure]
   742   C0025255:Membrane [Tissue]
   742   C0071524:polycarbonate [Biomedical or Dental Material,Organic Chemical]
   742   C0175905:Polycarbonate [Organic Chemical]
   742   C0596901:Membrane [Cell Component]
   742   C1301886:Diameter [Quantitative Concept]
   742   C1706182:Membrane [Manufactured Object]
   708   C0010453:Culture [Idea or Concept]
   708   C0220814:culture [Functional Concept]
   708   C0430400:Culture [Laboratory Procedure]
   708   C2242979:Culture [Laboratory Procedure]

Phrase: "with pore size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456389:size [Spatial Concept]
   861   C1325742:Pore [Cell Component]

Phrase: "of 0.4 m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "total insert growth area of 44 cm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017446:Area [Geographic Area]
   748   C0205146:Area [Spatial Concept]

Phrase: "(Costar 3419"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1140299:COSTAR [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.31: Initially cells were grown to confluence in 150-cm2 flasks, and the growth media was collected every 2 days. 

Phrase: "Initially cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown to confluence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0205200:Confluent [Qualitative Concept]

Phrase: "in 150-cm2 flasks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0872171:flasks [Medical Device]

Phrase: "and"

Phrase: "the growth media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0162867:Media [Tissue]
   861   C0220844:growth [Physiologic Function]
   861   C1254021:Media [Tissue]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "every 2 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442455:2 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.32: Spare media were stored at -20 C. 

Phrase: "Spare media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -20 C."
Processing 00000000.tx.33: EC and AS were then detached with trypsin and resuspended in fetal bovine serum. 

Phrase: "EC"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "AS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "detached with trypsin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C0687118:Detached [Functional Concept]
   790   C1561504:detached [Idea or Concept]

Phrase: "and"

Phrase: "resuspended in fetal bovine serum."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0007452:Bovine [Mammal]
   760   C0015965:Fetal [Embryonic Structure]
   760   C0229671:Serum [Body Substance]
   760   C0521457:Fetal [Functional Concept]
   760   C1140701:bovine [Mammal]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
Processing 00000000.tx.34: To study the reciprocal interactions between astrocytes and endothelial cells, both of which can lead to BBB induction, six different culturing conditions were set (Fig. 4). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the reciprocal interactions between astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "endothelial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "both of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "can"

Phrase: "lead to BBB induction,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0005854:BBB [Body Part, Organ, or Organ Component]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "six different culturing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "set (Fig. 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0036849:Set [Mental Process]
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]
   827   C1442518:Set [Functional Concept]
   827   C1705195:Set [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.35: Glial and endothelial cells were seeded at a density of 8 x 104/cm2. 

Phrase: "Glial"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027836:Glial [Cell]
   928 E C1087003:Glia [Plant]

Phrase: "and"

Phrase: "endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded at a density of 8 x 104/cm2."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0178587:density [Quantitative Concept]
   742   C0439479:cm2 [Quantitative Concept]
   742   C0555206:CM2 [Congenital Abnormality]
   708   C0036563:Seed [Plant]
   708   C1705192:Seed [Laboratory Procedure]
   708   C1882540:{Seed} [Quantitative Concept]
   708   C2346495:Seed [Conceptual Entity]
Processing 00000000.tx.36: Before cell loading, Transwell membranes were precoated with fibronectin on the luminal (i.e. 

Phrase: "Before cell loading,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]

Phrase: "Transwell membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "precoated with fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "on the luminal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0524462:Luminal [Spatial Concept]
   944 E C0031412:Phenobarbital [Organic Chemical,Pharmacologic Substance]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.37: "endothelial") side and with poly-D-lysine on the abluminal (i.e. 

Phrase: """endothelial"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014257:Endothelial [Tissue]

Phrase: ")"

Phrase: "side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441987:Side [Spatial Concept]

Phrase: "and with poly-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0747726:POLY [Conceptual Entity]
   790   C1515981:And [Idea or Concept]

Phrase: "D-"

Phrase: "lysine on the abluminal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.38: "astrocytic") side. 

Phrase: """astrocytic"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521395:Astrocytic [Body Location or Region]

Phrase: ")"

Phrase: "side."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441987:Side [Spatial Concept]
Processing 00000000.tx.39: Protein extracts were obtained from culture media samples of AS, EC, AS + EC, AS exposed to EC-conditioned media, and EC exposed to AS-conditioned media. 

Phrase: "Protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "obtained from culture media samples of AS,"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   778   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   757   C0430400:Sample culture [Laboratory Procedure]
           Culture
   757   C1277697:Sample obtained [Finding]
   757   C2242979:Sample culture [Laboratory Procedure]
           Culture
   748   C0004112:Astrocytes [Cell]
   748   C0009458:Media [Intellectual Product]
   748   C0010453:Culture [Idea or Concept]
   748   C0162867:Media [Tissue]
   748   C0220814:culture [Functional Concept]
   748   C1254021:Media [Tissue]
   748   C1301820:Obtained [Functional Concept]
   714   C0370003:Sample [Substance]
   714 E C0439536:Medium [Quantitative Concept]
   714 E C1705217:Medium [Substance]
   714 E C1706701:Obtain [Activity]
   714   C2347026:Sample [Conceptual Entity]
   714 E C3244283:medium [Intellectual Product]

Phrase: "EC,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "AS + EC,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0225336:Endothelial Cells [Cell]
   896   C0004112:astrocyte cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "AS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "exposed to EC-conditioned media,"
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   790   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   790   C0225336:Endothelial Cells [Cell]
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0007634:Cells [Cell]
   753   C0009458:Media [Intellectual Product]
   753   C0009647:Conditioned [Mental Process]
   753   C0014257:Endothelial [Tissue]
   753   C0162867:Media [Tissue]
   753   C1254021:Media [Tissue]
   753   C3282337:Cells [Cell]
   719 E C0439536:Medium [Quantitative Concept]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1705217:Medium [Substance]
   719 E C1948049:Cell [Spatial Concept]
   719 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "EC"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to AS-conditioned media."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0004112:Astrocytes [Cell]
   760   C0009458:Media [Intellectual Product]
   760   C0009647:Conditioned [Mental Process]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.40: To mimic an impaired BBB, EC-AS co-cultures were also grown spaced from each other by less than 1 mm of media between the cellular monolayers. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mimic"

Phrase: "an impaired BBB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005854:BBB [Body Part, Organ, or Organ Component]

Phrase: "EC-AS co-cultures"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   875   C0007585:cells cultures [Laboratory Procedure]
   840   C0282547:Co-cultures [Laboratory Procedure]
   804   C0010453:Cultures [Idea or Concept]
   771 E C0220814:culture [Functional Concept]
   771 E C0430400:Culture [Laboratory Procedure]
   771 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "also"

Phrase: "grown"

Phrase: "spaced from each other"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1883067:Space [Spatial Concept]

Phrase: "by less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "than 1 mm of media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0009458:Media [Intellectual Product]
   812   C0162867:Media [Tissue]
   812   C1254021:Media [Tissue]
   779 E C0439536:Medium [Quantitative Concept]
   779 E C1705217:Medium [Substance]
   779 E C3244283:medium [Intellectual Product]

Phrase: "between the cellular monolayers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872351:monolayers [Clinical Drug]
Processing 00000000.tx.41: View larger version (81K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(81K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.42: 4. 

Phrase: "4."
Processing 00000000.tx.43: 2M expression is increased under conditions mimicking BBB disruption in vitro. 

Phrase: "2M expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "increased under conditions"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   756   C0012634:condition [Disease or Syndrome]
   756   C0348080:Condition [Qualitative Concept]
   756   C1705253:Condition [Conceptual Entity]
   718 E C1517378:Gain [Quantitative Concept]
   706 E C0009647:Conditioned [Mental Process]
   706 E C1701901:Conditional [Qualitative Concept]
   706 E C1963686:Conditional [Functional Concept]

Phrase: "mimicking"

Phrase: "BBB disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332453:Disruption [Functional Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.44: The experimental design used is schematically shown in the left of the panel. 

Phrase: "The experimental design"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015320:Experimental Design [Research Activity]
  1000   C0035171:Experimental Design [Research Activity]
   861   C1517586:Experimental [Qualitative Concept]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "is"

Phrase: "schematically"

Phrase: "shown in the left of the panel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205091:Left [Spatial Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C1552822:left [Functional Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]
   714   C1547282:Show [Intellectual Product]
Processing 00000000.tx.45: The general design of the experiment consisted of either monocultures of human brain endothelial cells (1) or glia (3), co-cultures of the same cells exposed to reciprocal influences (6), or glial cells exposed to endothelial conditioned media (4) and vice versa (2). 

Phrase: "The general design of the experiment"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C0035171:Experiment Design [Research Activity]
   753   C1707689:Design [Activity]
   753   C2983265:DESIGN [Intellectual Product]
   748 E C0015320:Experimental Design [Research Activity]

Phrase: "consisted of either monocultures of human brain endothelial cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   764   C0225336:Endothelial Cells [Cell]
   762   C0427861:Human cells [Laboratory or Test Result]
   762   C0596208:brain cells [Cell]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0007634:Cells [Cell]
   742   C0014257:Endothelial [Tissue]
   742   C0086418:Human [Human]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C3282337:Cells [Cell]
   708   C0332529:CONSIST [Qualitative Concept]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "or"

Phrase: "glia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "co-cultures of the same cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0282547:Co-cultures [Laboratory Procedure]
   783   C0007585:cells cultures [Laboratory Procedure]
   753   C0010453:Cultures [Idea or Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "exposed to reciprocal influences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C1882911:Reciprocal [Qualitative Concept]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "glial cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0027836:Glial Cells [Cell]
           Glial
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1087003:Glia [Plant]

Phrase: "exposed to endothelial conditioned media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0009458:Media [Intellectual Product]
   760   C0009647:Conditioned [Mental Process]
   760   C0014257:Endothelial [Tissue]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "(4"

Phrase: ")"

Phrase: "and"

Phrase: "vice versa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814670:vice [Idea or Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.46: Finally to mimic an intact or breached BBB, glia and EC were grown in contact or separated by media (1 mm) (5). 

Phrase: "Finally to"

Phrase: "mimic"

Phrase: "an intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]

Phrase: "or"

Phrase: "breached BBB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005854:BBB [Body Part, Organ, or Organ Component]

Phrase: "glia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]

Phrase: "and"

Phrase: "EC"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown"

Phrase: "in contact"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0150312:In [Quantitative Concept]
   861   C0332158:contact [Functional Concept]
   861   C0332285:In [Spatial Concept]
   861   C0337611:Contact [Population Group]
   861   C1705415:Contact [Idea or Concept]

Phrase: "or"

Phrase: "separated by media"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0009458:Media [Intellectual Product]
   790   C0086972:Separated [Finding]
   790   C0162867:Media [Tissue]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]
   790   C1254021:Media [Tissue]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]

Phrase: "(1 mm) (5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0450316:1/5 [Quantitative Concept]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.47: Note that EC-conditioned media (media from EC culture) stimulated a minimal release of 2M by glia (4). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that EC-conditioned media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   812   C0009458:Media [Intellectual Product]
   812   C0162867:Media [Tissue]
   812   C1254021:Media [Tissue]
   779 E C0439536:Medium [Quantitative Concept]
   779 E C1705217:Medium [Substance]
   779 E C3244283:medium [Intellectual Product]

Phrase: "(media from EC culture"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C1139023:cell culture media [Indicator, Reagent, or Diagnostic Aid]
   797   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: ")"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "a minimal release of 2M"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "by glia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.48: Under the condition mimicking a breached BBB, a more significant release of 2M was observed (5). 

Phrase: "Under the condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "mimicking"

Phrase: "a breached BBB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005854:BBB [Body Part, Organ, or Organ Component]

Phrase: "a more significant release of 2M"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.49: Note that no detectable release was observed when AS were cultured alone (3) or in contact with EC (6). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "no detectable release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "AS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "or in contact with EC"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0225336:Endothelial Cells [Cell]
   790   C0332158:Contact with [Functional Concept]
           contact
   753   C0007634:Cells [Cell]
   753   C0014257:Endothelial [Tissue]
   753   C0337611:Contact [Population Group]
   753   C1705415:Contact [Idea or Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.50: These findings also suggest that release of 2M by glia occurs primarily when the environment is consistent with perivascular edema/BBB damage and EC and AS lose contact. 

Phrase: "These findings also"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that release of 2M"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "by glia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "primarily"

Phrase: "when"

Phrase: "the environment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014406:Environment [Spatial Concept]

Phrase: "is"

Phrase: "consistent with perivascular edema/BBB damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "EC"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "AS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "lose"

Phrase: "contact."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332158:contact [Functional Concept]
  1000   C0337611:Contact [Population Group]
  1000   C1705415:Contact [Idea or Concept]
Processing 00000000.tx.51: Astro, astrocytes; 

Phrase: "Astro,"

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: ";"
Processing 00000000.tx.52: Cond, conditioned; 

Phrase: "Cond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1856054:COND [Disease or Syndrome]
  1000   C2826243:COND [Intellectual Product]

Phrase: ","

Phrase: "conditioned"
Meta Candidates (Total=9; Excluded=8; Pruned=0; Remaining=1)
  1000   C0009647:Conditioned [Mental Process]
   966 E C0012634:condition [Disease or Syndrome]
   966 E C0348080:Condition [Qualitative Concept]
   966 E C1705253:Condition [Conceptual Entity]
   928 E C0040607:Training [Educational Activity]
   928 E C0220931:Training [Educational Activity]
   928 E C0336809:Train [Manufactured Object]
   928 E C1552514:Train [Manufactured Object]
   928 E C2673163:training [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.53: H, human.  

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "human."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]
Processing 00000000.tx.54: Patients The six patients whose serum samples were used for the study presented herein all participated in a BBBD trial for the treatment of primary central nervous system lymphoma. 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "The six patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "whose serum samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444266:Serum sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "used for the study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "herein"

Phrase: "all"

Phrase: "participated in a BBBD trial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0008976:Trial [Research Activity]
   760   C1511220:BBBD [Therapeutic or Preventive Procedure]

Phrase: "for the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of primary central nervous system lymphoma."
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
  1000   C0280803:Primary central nervous system lymphoma [Neoplastic Process]
   937   C0742472:Central Nervous System Lymphoma [Neoplastic Process]
   884   C0927232:Central Nervous System [Body System]
   884   C1269563:Central nervous system [Body System]
   840   C0027763:Nervous System [Body System]
   840   C0422837:NERVOUS SYSTEM [Finding]
   840   C1269560:Nervous system [Body System]
   804   C0024299:Lymphoma [Neoplastic Process]
   804   C0027769:Nervous [Sign or Symptom]
   804   C0205099:Central [Spatial Concept]
   804   C0205225:Primary [Qualitative Concept]
   804   C0439631:Primary [Therapeutic or Preventive Procedure]
   804   C0449913:System [Functional Concept]
   804   C0599851:Nervous [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   804   C1879652:Central - [Laboratory Procedure]
   784 E C0205494:Neurologic [Qualitative Concept]
   747 E C0027855:Neurology [Biomedical Occupation or Discipline]
   733 E C0205373:Systemic [Functional Concept]
   728 E C2707261:Neurological [Clinical Attribute]
Processing 00000000.tx.55: The Cleveland Clinic Brain Tumor Institute provides BBBD treatment (2729) for primary central nervous system lymphoma, primitive neuroectodermal tumors, some gliomas, central nervous system germinoma, and some metastatic brain tumors (such as breast, small cell lung, or germ cell). 

Phrase: "The Cleveland Clinic Brain Tumor Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0021622:institute [Organization]
   804   C1272753:Institute [Idea or Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "BBBD treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(2729"

Phrase: ")"

Phrase: "for primary central nervous system lymphoma,"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
  1000   C0280803:Primary central nervous system lymphoma [Neoplastic Process]
   937   C0742472:Central Nervous System Lymphoma [Neoplastic Process]
   884   C0927232:Central Nervous System [Body System]
   884   C1269563:Central nervous system [Body System]
   840   C0027763:Nervous System [Body System]
   840   C0422837:NERVOUS SYSTEM [Finding]
   840   C1269560:Nervous system [Body System]
   804   C0024299:Lymphoma [Neoplastic Process]
   804   C0027769:Nervous [Sign or Symptom]
   804   C0205099:Central [Spatial Concept]
   804   C0205225:Primary [Qualitative Concept]
   804   C0439631:Primary [Therapeutic or Preventive Procedure]
   804   C0449913:System [Functional Concept]
   804   C0599851:Nervous [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   804   C1879652:Central - [Laboratory Procedure]
   784 E C0205494:Neurologic [Qualitative Concept]
   747 E C0027855:Neurology [Biomedical Occupation or Discipline]
   733 E C0205373:Systemic [Functional Concept]
   728 E C2707261:Neurological [Clinical Attribute]

Phrase: "primitive neuroectodermal tumors,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0206663:Neuroectodermal Tumors, Primitive [Neoplastic Process]
   966 E C0206093:Primitive Neuroectodermal Tumor [Neoplastic Process]
           Neuroectodermal Tumors
   966 E C0279980:primitive neuroectodermal tumor [Neoplastic Process]
   827   C0027651:Tumors [Neoplastic Process]
   827   C3645627:Primitive [Intellectual Product]
   793 E C1578706:Tumor [Intellectual Product]
   793 E C3273930:Tumor [Finding]
   755   C1518271:Neuroectoderm [Embryonic Structure]

Phrase: "some gliomas,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0017638:[M]Gliomas [Neoplastic Process]
   966 E C0555198:[M]Glioma NOS [Neoplastic Process]
   966 E C2984291:Glioma [Functional Concept]

Phrase: "central nervous system germinoma,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1333813:Central Nervous System Germinoma [Neoplastic Process]
   812   C0206660:Germinoma [Neoplastic Process]
   812   C0854912:germinoma [Neoplastic Process]
   756   C0927232:Central Nervous System [Body System]
   756   C1269563:Central nervous system [Body System]

Phrase: "and"

Phrase: "some metastatic brain tumors"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   966   C0220650:metastatic brain tumor [Neoplastic Process]
   913   C0027627:metastatic tumors [Neoplastic Process]
   901   C0006118:Brain Tumors [Neoplastic Process]
   896 E C2939419:Tumor, metastatic [Neoplastic Process]
   896 E C2939420:Metastatic Tumor [Neoplastic Process]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0027651:Tumors [Neoplastic Process]
   827   C0036525:Metastatic [Functional Concept]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1522484:metastatic [Quantitative Concept]
   793 E C1578706:Tumor [Intellectual Product]
   793 E C3273930:Tumor [Finding]

Phrase: "("

Phrase: "such as breast,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0006141:Breast [Body Part, Organ, or Organ Component]
  1000   C1268990:Breast [Body Part, Organ, or Organ Component]
   944 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   944 E C1521735:Pectoral [Qualitative Concept]
   916 E C0817096:Chest [Body Location or Region]
   916 E C1527391:Chest [Body Location or Region]

Phrase: "small cell lung,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   871   C2749705:Small lungs [Finding]
   827   C0024109:Lung [Body Part, Organ, or Organ Component]
   827   C0819757:LUNG [Tissue]
   827   C1278908:Lung [Body Part, Organ, or Organ Component]
   771 E C2707265:Pulmonary [Clinical Attribute]
   771 E C2709248:Pulmonary [Qualitative Concept]
   734 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "or"

Phrase: "germ cell"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0017471:Germ cell [Cell]
  1000   C1517530:Germ Cell [Cell]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1517528:Germ [Idea or Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.56: These patients were treated with intra-arterial injection of mannitol causing a temporary disruption of the BBB followed by a selective methotrexate injection into the cerebral circulation directly thereafter. 

Phrase: "These patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "treated with intra-arterial injection of mannitol"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   814   C0021487:Intra-arterial injection [Functional Concept]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   778   C0694634:Intra-arterial [Spatial Concept]
   774   C0309448:MANNITOL INJECTION [Clinical Drug]
   748   C0003842:Arterial [Body Part, Organ, or Organ Component]
   748   C0021485:injection [Therapeutic or Preventive Procedure]
   748   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]
   748   C0221464:Arterial [Spatial Concept]
   748   C0347985:Intra [Temporal Concept]
   748   C1272883:Injection [Biomedical or Dental Material]
   748   C1522326:Treated [Functional Concept]
   748   C1533685:Injection [Therapeutic or Preventive Procedure]
   748   C1828121:Injection [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "a temporary disruption of the BBB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332453:Disruption [Functional Concept]

Phrase: "followed by a selective methotrexate injection"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0021485:injection [Therapeutic or Preventive Procedure]
   753   C0025677:Methotrexate [Organic Chemical,Pharmacologic Substance]
   753   C1272883:Injection [Biomedical or Dental Material]
   753   C1533685:Injection [Therapeutic or Preventive Procedure]
   753   C1828121:Injection [Functional Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "into the cerebral circulation directly thereafter."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007818:cerebral circulation [Organ or Tissue Function]
   812   C0005775:Circulation [Physiologic Function]
   812   C1516559:Circulation [Organism Function]
   812   C1947931:Directly [Qualitative Concept]
Processing 00000000.tx.57: Blood samples were collected before (10 min prior to mannitol injection), during (45 s, 1 min, and 10 min after mannitol injection), and after (up to 6 h) iatrogenic selective intra-arterial osmotic opening of the BBB (30, 31, 33, 51). 

Phrase: "Blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "(10 min prior to mannitol injection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0456692:/10 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "during"

Phrase: "(45 s,"

Phrase: "1 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "10 min after mannitol injection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0456692:/10 min [Temporal Concept]
   760   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "after"

Phrase: "("

Phrase: "up to 6 h) iatrogenic selective intra-arterial osmotic opening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0175566:Opening [Spatial Concept]
   793   C1882151:Opening [Spatial Concept]

Phrase: "of the BBB (30,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005854:BBB [Body Part, Organ, or Organ Component]

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "33,"

Phrase: "51"

Phrase: ")."
Processing 00000000.tx.58: Efficacy of BBBD was assessed by computed tomography scans and, indirectly, by measuring S100 level in plasma (30, 31). 

Phrase: "Efficacy of BBBD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280519:Efficacy [Qualitative Concept]
   790   C1707887:EFFICACY [Research Activity]

Phrase: "was"

Phrase: "assessed by computed tomography scans"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0040405:computed tomography [Diagnostic Procedure]
           tomography
   806   C1552357:Computed Tomography [Professional or Occupational Group]
   760   C0034606:Scan [Diagnostic Procedure]
   760   C0040395:tomography [Diagnostic Procedure]
   760   C0441633:Scan [Diagnostic Procedure]
   760   C1441526:Computed [Laboratory Procedure]
   760   C1516048:Assessed [Activity]
   760   C1880157:Computed [Activity]
   760   C2826292:SCAN [Finding]

Phrase: "and"

Phrase: ","

Phrase: "indirectly,"

Phrase: "by measuring S100 level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "in plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.59: All patients signed an informed consent form prior to the procedure. 

Phrase: "All patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "signed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1519316:Signed [Intellectual Product]
  1000   C1561610:signed [Idea or Concept]
   966 E C0311392:Sign [Finding]
   966 E C1547188:Sign [Idea or Concept]

Phrase: "an informed consent form prior to the procedure."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0009797:Informed Consent Form [Intellectual Product]
           Consent Form
   800   C1880840:Informed Consent Form [Manufactured Object]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]
Processing 00000000.tx.60: Experiments with human subjects were performed in agreement with National Institutes of Health and Cleveland Clinic Foundation guidelines. 

Phrase: "Experiments with human subjects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "were"

Phrase: "performed in agreement"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "Cleveland Clinic Foundation guidelines."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0162791:Guidelines [Intellectual Product]
   812   C0220845:guidelines [Intellectual Product]
   812   C0282423:guidelines [Intellectual Product]
Processing 00000000.tx.61: Two-dimensional Gel Electrophoresis The proteins in aliquots of the respective conditioned media (or human serum in the case of BBBD protocol) were precipitated with acetone and reconstituted in an isoelectric focusing buffer consisting of 6 M urea, 2 M thiourea, 2% Chaps, 1% Triton X-100, 1% ampholytes, and 50 mM dithiothreitol. 

Phrase: "Two-dimensional Gel Electrophoresis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   923   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   861   C1705052:2-Dimensional [Spatial Concept]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0205448:Two [Quantitative Concept]
   812   C1382104:Gel [Substance]
   741   C0439534:Dimension [Quantitative Concept]
   741   C1707753:Dimensionality [Spatial Concept]

Phrase: "The proteins in aliquots of the respective conditioned media"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "or"

Phrase: "human serum in the case of BBBD protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0086418:Human [Human]
   744   C0229671:Serum [Body Substance]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]

Phrase: ")"

Phrase: "were"

Phrase: "precipitated with acetone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]
   756   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "and"

Phrase: "reconstituted in an isoelectric focusing buffer"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0022169:Isoelectric Focusing [Laboratory Procedure]
   753   C0000936:focusing [Clinical Attribute]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C2981153:Focusing [Finding]
   719 E C0205234:Focus [Spatial Concept]
   719 E C1285542:focus [Functional Concept]

Phrase: "consisting of 6 M urea,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   726   C0332529:CONSIST [Qualitative Concept]
   704 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "2 M thiourea,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0039958:2-Thiourea [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Thiourea

Phrase: "2% Chaps,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   827 E C0950540:chap [Therapeutic or Preventive Procedure]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "1% ampholytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002677:Ampholytes [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "50 mM dithiothreitol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.62: Isoelectric focusing was carried out for 43 kV-h at 20 C in 11-cm immobilized pH gradient strips (Bio-Rad) covering pI 58, which were loaded with 500 g of total protein using the active rehydration method. 

Phrase: "Isoelectric focusing"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0022169:Isoelectric Focusing [Laboratory Procedure]
   861   C0000936:focusing [Clinical Attribute]
   861   C2981153:Focusing [Finding]
   827 E C0205234:Focus [Spatial Concept]
   827 E C1285542:focus [Functional Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out for 43 kV-h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0439787:Out [Spatial Concept]
   760   C0441932:H+ [Classification]
   760   C0556639:kV [Quantitative Concept]
   760   C0564385:/h [Quantitative Concept]
   760   C0849355:Out [Qualitative Concept]

Phrase: "at 20 C in 11-cm immobilized pH gradient strips"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C1321564:strips [Medical Device]
   791   C1441593:Gradient strip [Laboratory Procedure]

Phrase: "(Bio-Rad) covering pI 58,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   804   C0180153:covering [Medical Device]
   804   C0429863:PI [Clinical Attribute]
   804   C0439844:covering [Functional Concept]
   804   C3537219:PI [Gene or Genome]
   804   C3539772:PI [Intellectual Product]
   771 E C1707529:Cover [Medical Device]
   771 E C1999244:Cover [Functional Concept]

Phrase: "which"

Phrase: "were"

Phrase: "loaded with 500 g of total protein"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0555903:Total protein [Laboratory Procedure]
   778   C1261360:total protein [Laboratory or Test Result]
   774   C0060916:protein g [Amino Acid, Peptide, or Protein]
   774   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   774 E C0439177:Protein.total [Quantitative Concept]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439175:% total [Quantitative Concept]
   748   C0439267:g% [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the active rehydration method."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1704532:Active Method [Therapeutic or Preventive Procedure]
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.63: The second dimension was carried out in precast 12% SDS-polyacrylamide gels (Criterion gels, Bio-Rad). 

Phrase: "The second dimension"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439534:Dimension [Quantitative Concept]
   761 E C1707753:Dimensionality [Spatial Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in precast 12% SDS-polyacrylamide gels"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C0439787:Out [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]
   714 E C1382104:Gel [Substance]

Phrase: "(Criterion gels,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "Bio-Rad"

Phrase: ")."
Processing 00000000.tx.64: Gels were subsequently fixed and stained with Coomassie Blue (GelCode Blue, Pierce). 

Phrase: "Gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "subsequently"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "stained with Coomassie Blue"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   770   C1260957:Blue [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(GelCode Blue,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1260957:Blue [Qualitative Concept]

Phrase: "Pierce"

Phrase: ")."
Processing 00000000.tx.65: Mass Spectroscopy We used a liquid chromatography-mass spectrometry system with a Protana microelectrospray ion source interfaced to a self-packed 10-cm x 75-m-inner diameter Phenomenex Jupiter C18 reversed-phase capillary chromatography column. 

Phrase: "Mass Spectroscopy"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0037813:Spectroscopy, Mass [Laboratory Procedure]
   861   C0037812:spectroscopy [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C2713504:Spectroscopy [Occupation or Discipline]
   861   C2984732:SPECTROSCOPY [Functional Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a liquid chromatography-mass spectrometry system with a Protana microelectrospray ion source"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0449913:System [Functional Concept]
   736   C1553451:System [Manufactured Object]
   736   C1704459:System [Medical Device]

Phrase: "interfaced to a self-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0036588:Self [Idea or Concept]
   770   C1551994:self [Intellectual Product]
   770   C3244295:Self [Intellectual Product]
   737   C1708533:Interface [Manufactured Object]
   737   C2698172:Interface [Intellectual Product]

Phrase: "packed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0184967:Packed [Therapeutic or Preventive Procedure]
   966 E C1968515:Pack [Medical Device]
   966 E C2825051:Pack [Drug Delivery Device]
   966 E C2828395:Pack [Activity]

Phrase: "10-cm x 75-"

Phrase: "m-"

Phrase: "inner diameter Phenomenex Jupiter C18 reversed-phase capillary chromatography column."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0684296:Chromatography.column [Laboratory Procedure]
   790   C1185738:Column [Body Part, Organ, or Organ Component]
   790   C1706132:Column [Idea or Concept]
Processing 00000000.tx.66: Data were analyzed by using all collision-induced dissociation spectra collected in the experiment to search the National Center for Biotechnology Information (NCBI) non-redundant data base with the search program TurboSequest. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "all collision-induced dissociation spectra"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1883073:Spectrum [Quantitative Concept]
   779   C2827424:Spectrum [Conceptual Entity]
   756   C1707433:Collision-Induced Dissociation [Research Activity]

Phrase: "collected in the experiment to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0681814:Experiment [Research Activity]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   760   C1706386:Experiment [Conceptual Entity]

Phrase: "search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552603:search [Intellectual Product]
  1000   C1706202:Search [Activity]

Phrase: "the National Center for Biotechnology Information (NCBI) non-redundant data base"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   807   C0242356:Database [Intellectual Product]
   807   C0993637:Data Base [Intellectual Product]
   791   C0002055:base [Inorganic Chemical]
   791   C0178499:Base [Chemical Viewed Functionally]
   791   C1511726:Data [Idea or Concept]
   791   C1880279:Base [Biomedical or Dental Material]
   791   C3245479:data [Medical Device]
   720 E C0205112:Basal [Spatial Concept]
   708 E C0016617:Foundation [Organization]
   708 E C1626935:Bases [Quantitative Concept]
   707   C1705803:National Center for Biotechnology Information [Organization]

Phrase: "with the search program TurboSequest."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2348167:Search Program [Intellectual Product]
Processing 00000000.tx.67: All matching spectra were verified by manual interpretation. 

Phrase: "All matching spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "verified by manual interpretation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0024763:Manual [Intellectual Product,Manufactured Object]
   770   C0175674:Manual [Functional Concept]
   770   C0459471:Interpretation [Intellectual Product]
   770   C1711411:Verified [Functional Concept]
   770   C3173575:Interpretation [Clinical Attribute]
Processing 00000000.tx.68: The interpretation process was also aided by additional searches using Mascot and Fasta. 

Phrase: "The interpretation process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0459471:Interpretation Process [Intellectual Product]
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "was"

Phrase: "also"

Phrase: "aided by additional searches"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1524062:Additional [Functional Concept]
   737   C0018896:Aid [Social Behavior]
   737   C0449435:Aid [Manufactured Object]
   737   C1552603:search [Intellectual Product]
   737   C1706202:Search [Activity]
   737   C3540469:AID [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Mascot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347074:Mascot [Intellectual Product]

Phrase: "and"

Phrase: "Fasta."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708003:FASTA [Qualitative Concept]
Processing 00000000.tx.69: S100 was measured by techniques described elsewhere (32). 

Phrase: "S100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441165:S-100 [Immunologic Factor]
  1000   C3273837:S100 [Gene or Genome]
  1000   C3274824:S100 [Gene or Genome]

Phrase: "was"

Phrase: "measured by techniques"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0025664:techniques [Intellectual Product]
   790   C0444706:Measured [Qualitative Concept]
   790   C0449851:Techniques [Functional Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.70: The enzyme-linked immunosorbent assay kits were kindly provided by Dr. 

Phrase: "The enzyme-linked immunosorbent assay kits"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   804   C1690540:Kits [Qualitative Concept]
   771   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   771 E C0812225:KIT [Medical Device]
   771 E C1150635:KIT [Molecular Function]
   771 E C1705212:Kit [Medical Device]
   771 E C1705213:KIT [Medical Device]
   771 E C3273202:Kit [Manufactured Object]
   708   C2717977:Enzyme Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.71: Anne-Charlotte Aronsson (Sangtec Medical, Bromma, Sweden). 

Phrase: "Anne-Charlotte Aronsson"

Phrase: "(Sangtec Medical, Bromma,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")."
Processing 00000000.tx.72: Relative Protein Density on Two-dimensional Gel Two-dimensional protein gels were scanned using a 35-mm camera mounted on a gel-scanning unit interfaced to a PC using GelProTM analysis software. 

Phrase: "Relative Protein Density on Two-dimensional Gel Two-dimensional protein gels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0037786:Relative Density [Quantitative Concept]
   754   C1576416:*Relative Density [Qualitative Concept]
   738   C0178587:density [Quantitative Concept]

Phrase: "were"

Phrase: "scanned"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441633:scanned [Diagnostic Procedure]
   966 E C0034606:Scan [Diagnostic Procedure]
   966 E C2826292:SCAN [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 35-mm camera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0179533:Camera [Medical Device]
   827   C1654607:Camera [Eukaryote]
   827   C1706254:CAMERA [Medical Device]

Phrase: "mounted on a gel-scanning unit"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0034606:Scanning [Diagnostic Procedure]
   753   C0439148:Unit [Quantitative Concept]
   753   C0441633:Scanning [Diagnostic Procedure]
   753   C0449878:mounted [Finding]
   753   C1382104:Gel [Substance]
   753   C1519795:Unit [Quantitative Concept]
   753   C1704753:Unit [Manufactured Object]
   753   C1880519:Unit [Quantitative Concept]
   719 E C0181909:Mount [Medical Device]
   719 E C2826292:SCAN [Finding]

Phrase: "interfaced to a PC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C3540812:PC [Gene or Genome]
   737   C1708533:Interface [Manufactured Object]
   737   C2698172:Interface [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GelProTM analysis software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.73: The scanned black and white image was saved in a TIFF format and further analyzed using macros specifically developed for the Adobe Photoshop platform. 

Phrase: "The scanned black and white image"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1704254:Image [Intellectual Product]
   804   C1704922:Image [Entity]
   804   C3542466:Image [Intellectual Product]
   717   C1609177:Black and White [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "saved in a TIFF format"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1301627:Format [Intellectual Product]
   760   C2348636:TIFF [Functional Concept]
   726   C2347840:Save [Machine Activity]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "macros specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2984010:Macro [Conceptual Entity]

Phrase: "developed for the Adobe Photoshop platform."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710360:Platform [Research Device]
Processing 00000000.tx.74: The histogram function provided information on the number of pixels of the selected area. 

Phrase: "The histogram function provided information on the number of pixels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1533716:Information [Idea or Concept]

Phrase: "of the selected area."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]
Processing 00000000.tx.75: Tracings were performed in triplicate, and data were averaged and expressed as mean  S.E. 

Phrase: "Tracings"

Phrase: "were"

Phrase: "performed in triplicate,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "and"

Phrase: "expressed as mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444504:Mean [Quantitative Concept]
   790   C2347634:Mean [Quantitative Concept]
   790   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.76: The density of the protein pattern for haptoglobin was used as normalizing value to account for variability between gels. 

Phrase: "The density of the protein pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178587:density [Quantitative Concept]

Phrase: "for haptoglobin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018595:Haptoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "used as normalizing value to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C1273517:used [Finding]
   760   C1522609:Value [Quantitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726   C1882115:Normalize [Research Activity]
   726 E C1947944:Use [Intellectual Product]

Phrase: "account for variability"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1551359:account [Idea or Concept]
   790   C2741673:Account # [Clinical Attribute]
   790   C2827666:Variability [Conceptual Entity]
   790   C2981730:Account [Classification]
   718 E C0439828:Variable [Qualitative Concept]

Phrase: "between gels."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]
Processing 00000000.tx.77: Western Blotting Identification of 2M protein was also performed by Western blotting techniques. 

Phrase: "Western Blotting Identification of 2M protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "performed by Western blotting techniques."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   806   C1550369:Performed By [Qualitative Concept]
   790 E C0949466:Western Blot [Laboratory Procedure]
   760   C0025664:techniques [Intellectual Product]
   760   C0449851:Techniques [Functional Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.78: Serum samples were obtained from the BBBD procedures and media samples from the co-cultures. 

Phrase: "Serum samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444266:Serum sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "obtained from the BBBD procedures"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0025664:procedures [Intellectual Product]
   760   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C1301820:Obtained [Functional Concept]
   760   C1511220:BBBD [Therapeutic or Preventive Procedure]
   760   C2700391:procedures [Activity]
   726 E C1706701:Obtain [Activity]
   726 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   726 E C3274430:PROCEDURE [Health Care Activity]
   726 E C3538935:Procedure [Idea or Concept]
   726 E C3539779:Procedure [Intellectual Product]

Phrase: "and"

Phrase: "media samples from the co-cultures."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C0430400:Sample culture [Laboratory Procedure]
   750   C2242979:Sample culture [Laboratory Procedure]
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.79: Protein concentration was estimated according to the Bradford assay method (Bio-Rad). 

Phrase: "Protein concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427716:Protein concentration [Laboratory Procedure]
  1000   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "estimated according to the Bradford assay method"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0025663:Method [Intellectual Product]
   748   C0243073:assay [Qualitative Concept]
   748   C0449851:Method [Functional Concept]
   748   C0680240:according [Social Behavior]
   748   C0750572:Estimated [Quantitative Concept]
   748   C0871511:METHOD [Intellectual Product]
   748   C1510438:Assay [Laboratory Procedure]

Phrase: "(Bio-Rad"

Phrase: ")."
Processing 00000000.tx.80: Total proteins (50 g/lane) were separated on 12% polyacrylamide gels with SDS-PAGE at 80 V and transferred onto a polyvinylidene difluoride membrane (Millipore Corp., Bedford, MA) by electroblotting overnight at 40 mA of constant current. 

Phrase: "Total proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0555903:Total protein [Laboratory Procedure]
   966   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "(50 g/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "separated on 12% polyacrylamide gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   726 E C1382104:Gel [Substance]

Phrase: "with SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "at 80 V"

Phrase: "and"

Phrase: "transferred onto a polyvinylidene difluoride membrane"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0071710:polyvinylidene difluoride [Organic Chemical]
   753   C0025255:Membrane [Tissue]
   753   C0348011:transferred [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]

Phrase: "(Millipore Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "Bedford,"

Phrase: "MA) by electroblotting"

Phrase: "overnight at 40 mA of constant current."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.81: After blocking with Blotto (phosphate-buffered saline, 1% milk powder, and 0.05% Tween 20) for at least 2 h, the membrane was probed overnight at 4 C with primary 2M goat anti-human antibody (1:1000, Sigma). 

Phrase: "After"

Phrase: "blocking with Blotto"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0233660:Blocking [Mental or Behavioral Dysfunction]
   790   C0332206:Blocking [Functional Concept]
   756 E C0028778:Block [Pathologic Function]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "(phosphate-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1% milk powder,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C1440965:Milk powder [Immunologic Factor]
   827   C0026131:Milk [Body Substance]
   827   C0032861:Powder [Biomedical or Dental Material]
   827   C0349374:Milk [Food]
   827   C0444318:Milk [Substance]
   827   C1382110:Powder [Substance]
   827   C2825079:Milk [Food]
   771 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   771 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   755 E C0443260:Milky [Finding]

Phrase: "and"

Phrase: "0.05% Tween 20"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "for"

Phrase: "at least 2 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "probed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0182400:Probe [Medical Device]
   966   C1704681:Probe [Gene or Genome]
   966   C2347609:Probe [Chemical Viewed Functionally]
   966   C3536729:Probe [Manufactured Object]

Phrase: "overnight at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]

Phrase: "with primary 2M goat anti-human antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000,"

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: After a series of washes, the membrane was incubated with secondary horseradish peroxidase-conjugated anti-goat IgG antibody (rabbit) (1:5000, Calbiochem) for 2 h. 

Phrase: "After a series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of washes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0441648:Wash [Activity]

Phrase: "the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "incubated with secondary horseradish peroxidase-conjugated anti-goat IgG antibody"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   777   C0063351:IGG-horseradish peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   760   C2754943:IgG antibody [Cell Component]
   757   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0018019:goat [Mammal]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0027627:secondary [Neoplastic Process]
   739   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0175668:Secondary [Temporal Concept]
   739   C0205436:Secondary [Quantitative Concept]
   739   C0330510:Horseradish [Food]
   739   C0522529:Conjugated [Spatial Concept]
   739   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   739   C1110641:Horseradish [Plant]
   739   C1265549:goat [Mammal]
   739   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   739   C1439852:Incubated [Laboratory Procedure]
   739   C1510458:Goat [Mammal]

Phrase: "(rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: ")"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5000,"

Phrase: "Calbiochem"

Phrase: ")"

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.83: Specific blots were visualized by enhanced chemiluminescence reagent (ECL Plus, Amersham Biosciences). 

Phrase: "Specific blots"

Phrase: "were"

Phrase: "visualized by enhanced chemiluminescence reagent"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   760   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   760   C0234621:Visualized [Functional Concept]
   760   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   760   C2349975:Enhanced [Activity]

Phrase: "(ECL Plus, Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.84: For media samples, to ensure that the same amount of total protein was electroblotted, polyvinylidene difluoride membranes were incubated for 30 min at 50 C in a "stripping buffer" (100 mM 2-mercaptoethanol, 2% sodium dodecyl sulfate, 62.5 mM Tris-HCl, pH 6.7). 

Phrase: "For media samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "the same amount of total protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "electroblotted"

Phrase: ","

Phrase: "polyvinylidene difluoride membranes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]
   734   C0071710:polyvinylidene difluoride [Organic Chemical]

Phrase: "were"

Phrase: "incubated for 30 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 50 C in a ""stripping buffer"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(100 mM 2-mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "2% sodium dodecyl sulfate,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   875   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "62.5 mM Tris-HCl,"

Phrase: "pH 6.7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.85: Nonspecific binding blocking was performed as described above; 

Phrase: "Nonspecific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "was"

Phrase: "performed as described above"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0884358:Performed [Functional Concept]
   770   C1552738:described [Idea or Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.86: membranes were reprobed with rabbit anti-bovine albumin antibodies (1:1000, Calbiochem; 

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "reprobed with rabbit anti-bovine albumin antibodies"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   774   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0007452:Bovine [Mammal]
   748   C0034493:Rabbit [Mammal]
   748   C1140701:bovine [Mammal]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000,"

Phrase: "Calbiochem"

Phrase: ";"
Processing 00000000.tx.87: see Fig. 

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.88: 5). 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.89: View larger version (37K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.90: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.91: Western blot analysis demonstrating increased expression of 2M in media obtained from glial-endothelial co-cultures. 

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "demonstrating"

Phrase: "increased expression of 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "obtained from glial-endothelial co-cultures."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0282547:Co-cultures [Laboratory Procedure]
   753   C0010453:Cultures [Idea or Concept]
   753   C0014257:Endothelial [Tissue]
   753   C0027836:Glial [Cell]
   753   C1301820:Obtained [Functional Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]
   719 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.92: Data from one representative experiment are shown (upper panel). 

Phrase: "Data from one representative experiment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.93: The identical membranes were stripped and reprobed with anti-bovine albumin antibody to evaluate loaded protein levels (lower panel). 

Phrase: "The identical membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "stripped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1321564:Strip [Medical Device]

Phrase: "and"

Phrase: "reprobed with anti-bovine albumin antibody to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0007452:Bovine [Mammal]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C1140701:bovine [Mammal]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "loaded protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C0428479:Protein level [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.94: Human 2M and bovine albumin were loaded on the first lane and considered as standard.  

Phrase: "Human 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "bovine albumin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0007452:Bovine [Mammal]
   861   C1140701:bovine [Mammal]

Phrase: "were"

Phrase: "loaded on the first lane"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C1708639:Lane [Spatial Concept]
   760   C1708715:Loaded [Activity]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "considered as standard."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0750591:considered [Idea or Concept]
   790   C1442989:Standard [Qualitative Concept]
   790   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.95: Relative expression of proteins was determined by densitometric analysis using Scion Image Software. 

Phrase: "Relative expression of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1171362:expression protein [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "determined by densitometric analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Scion Image Software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.96: Human 2M (Calbiochem) for the BBBD experiment and bovine albumin (Calbiochem) for the cell culture experiment were used as protein standards. 

Phrase: "Human 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: "for the BBBD experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "bovine albumin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0007452:Bovine [Mammal]
   861   C1140701:bovine [Mammal]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: "for the cell culture experiment"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0681814:Experiment [Research Activity]
   827   C1706386:Experiment [Conceptual Entity]
   755 E C1517586:Experimental [Qualitative Concept]
   734   C0007585:Cell Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "used as protein standards."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0038137:standards [Intellectual Product]
   770   C0175675:Standards [Qualitative Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1442989:Standard [Qualitative Concept]
   737 E C1947944:Use [Intellectual Product]
   737 E C2828392:Standard [Intellectual Product]
Processing 00000000.tx.97: Relative Protein Density on Western Blot Western blots were scanned on a scanner interfaced with a PC using ScanSoftTM analysis software. 

Phrase: "Relative Protein Density on Western Blot Western blots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0037786:Relative Density [Quantitative Concept]
   767   C1576416:*Relative Density [Qualitative Concept]
   744   C0178587:density [Quantitative Concept]

Phrase: "were"

Phrase: "scanned on a scanner"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0183115:scanner [Medical Device]
   770   C0441633:scanned [Diagnostic Procedure]
   770   C1710020:Scanner [Medical Device]
   737 E C0034606:Scan [Diagnostic Procedure]
   737 E C2826292:SCAN [Finding]

Phrase: "interfaced with a PC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C3540812:PC [Gene or Genome]
   737   C1708533:Interface [Manufactured Object]
   737   C2698172:Interface [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ScanSoftTM analysis software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.98: The scanned black and white images were saved in a TIFF format and further analyzed using macros specifically developed on a Adobe Photoshop platform. 

Phrase: "The scanned black and white images"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   771   C1704254:Image [Intellectual Product]
   771   C1704922:Image [Entity]
   771   C3542466:Image [Intellectual Product]
   717   C1609177:Black and White [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "saved in a TIFF format"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1301627:Format [Intellectual Product]
   760   C2348636:TIFF [Functional Concept]
   726   C2347840:Save [Machine Activity]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "macros specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2984010:Macro [Conceptual Entity]

Phrase: "developed on a Adobe Photoshop platform."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710360:Platform [Research Device]
Processing 00000000.tx.99: We first calculated a calibration curve by measuring the number of pixels of 2M bovine albumin standards. 

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "a calibration curve by measuring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205134:Curve [Spatial Concept]

Phrase: "the number of pixels of 2M bovine albumin standards."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0237753:*Number [Quantitative Concept]
   739   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.100: Density of the protein spots was transformed in nanograms by comparison with the standard. 

Phrase: "Density of the protein spots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0178587:density [Quantitative Concept]

Phrase: "was"

Phrase: "transformed in nanograms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439212:nanograms [Quantitative Concept]
   790   C1510411:Transformed [Pathologic Function]

Phrase: "by comparison with the standard."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1442989:Standard [Qualitative Concept]
  1000   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.101: Radial Immunodiffusion Test This technique was used to quantitatively determine the concentration of 2M, haptoglobin-1, and S100 in human serum. 

Phrase: "Radial Immunodiffusion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0017231:Immunodiffusion [Laboratory Procedure]
   861   C0442038:Radial [Conceptual Entity]
   861   C0920847:Radial [Conceptual Entity]

Phrase: "Test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "This technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449851:Technique [Functional Concept]
   916 E C0025664:techniques [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to quantitatively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the concentration of 2M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "haptoglobin-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018595:Haptoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "S100 in human serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1441165:S-100 [Immunologic Factor]
   770   C3273837:S100 [Gene or Genome]
   770   C3274824:S100 [Gene or Genome]
Processing 00000000.tx.102: Prefabricated immunodiffusion plates were purchased from Kent Laboratories, Inc. 

Phrase: "Prefabricated immunodiffusion plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "purchased from Kent Laboratories,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C0454861:Kent [Geographic Area]
   770   C0869011:purchased [Activity]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C3244292:laboratory [Functional Concept]

Phrase: "Inc."
Processing 00000000.tx.103: (Bellingham, WA) containing antiserum to one of the three proteins in a medium of agarose gel, 0.1 M phosphate-buffered saline, pH 7.0, with 0.1% sodium azide. 

Phrase: "(Bellingham,"

Phrase: "WA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043038:WA [Geographic Area]

Phrase: ")"

Phrase: "containing antiserum to one of the three proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in a medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "of agarose gel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1706746:Agarose Gel [Research Device]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "0.1 M phosphate-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   810   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   799   C0031701:phosphate [Organophosphorus Compound]
   799   C0036082:Saline [Substance]
   799   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "with 0.1% sodium azide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0074721:Sodium Azide [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   812   C0004492:azide [Chemical Viewed Structurally]
Processing 00000000.tx.104: Standards and samples were pipetted at constant volume (5 l) to individually prelabeled wells 3 mm in diameter. 

Phrase: "Standards"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038137:standards [Intellectual Product]
  1000   C0175675:Standards [Qualitative Concept]
   966 E C1442989:Standard [Qualitative Concept]
   966 E C2828392:Standard [Intellectual Product]

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "pipetted at constant volume"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0449468:*Volume [Quantitative Concept]
   770   C1547014:*Constant [Quantitative Concept]
   770   C1690016:% volume [Qualitative Concept]
   770   C1705102:Volume [Intellectual Product]
   770   C1948059:Constant [Qualitative Concept]
   770   C2700258:Volume [Laboratory Procedure]
   737   C0182301:Pipette [Medical Device]
   737   C1706407:Pipette [Medical Device]

Phrase: "(5 l) to individually prelabeled wells 3 mm in diameter."
Processing 00000000.tx.105: The plates are manufactured with 24 wells/plate. 

Phrase: "The plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "are"

Phrase: "manufactured with 24 wells/plate."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0005971:Plate [Medical Device]
   760   C0870840:manufactured [Occupational Activity]
   760   C1139930:plate [Medical Device]
   760   C3537155:Plate [Manufactured Object]
   726   C0205170:Well [Qualitative Concept]
   726   C3146287:Well [Manufactured Object]
Processing 00000000.tx.106: The proteins were allowed to diffuse to their end point following incubation at room temperature (2024 C) for 48 h. 

Phrase: "The proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "diffuse to their end point"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C2349179:End Point [Qualitative Concept]
   806   C2826544:ENDPOINT [Quantitative Concept]
   760   C0205219:Diffuse [Qualitative Concept]
   760   C0444930:End [Spatial Concept]
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation at room temperature"

Phrase: "(2024 C) for 48 h."
Processing 00000000.tx.107: Following incubation the diameters of the precipitin arcs formed at the periphery of each well were measured with a jewelers loupe (7x magnification) to the nearest 0.1 mm. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation"

Phrase: "the diameters of the precipitin arcs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1301886:diameters [Quantitative Concept]

Phrase: "formed at the periphery of each well"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0205170:Well [Qualitative Concept]
   748   C0205431:Formed [Functional Concept]
   748   C3146287:Well [Manufactured Object]
   714 E C0348078:Form [Qualitative Concept]
   714 E C0376315:Form [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "measured with a jewelers loupe"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0336139:jewelers [Professional or Occupational Group]
   760   C0444706:Measured [Qualitative Concept]
   760   C0549181:loupe [Medical Device]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "(7x magnification"

Phrase: ")"

Phrase: "to the nearest 0.1 mm."
Processing 00000000.tx.108: A linear plot of the radial diffusion (in mm2) was plotted versus concentration of each protein (mg/dl). 

Phrase: "A linear plot of the radial diffusion"

Phrase: "("

Phrase: "in mm2)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456786:mm2 [Quantitative Concept]

Phrase: "was"

Phrase: "plotted"

Phrase: "versus"

Phrase: "concentration of each protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0427716:Protein concentration [Laboratory Procedure]
   819   C1304757:Protein concentration [Laboratory or Test Result]
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "(mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439269:mg dl [Quantitative Concept]
   861   C3642216:/dL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.109: Samples and standards were run in duplicate to yield slopes consistent with the quality control data provided in the package insert. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "standards"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038137:standards [Intellectual Product]
  1000   C0175675:Standards [Qualitative Concept]
   966 E C1442989:Standard [Qualitative Concept]
   966 E C2828392:Standard [Intellectual Product]

Phrase: "were"

Phrase: "run in"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C3274438:RUN-IN [Temporal Concept]
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "duplicate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205173:Duplicate [Functional Concept]
  1000   C3539942:Duplicate [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "yield"

Phrase: "slopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0807955:Slope [Quantitative Concept]

Phrase: "consistent with the quality control data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "provided in the package insert."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0030174:Package Insert [Manufactured Object]
   806   C1705425:package insert [Intellectual Product]
   760   C0013194:Package [Medical Device]
   760   C0441587:Insert [Health Care Activity]
   760   C1743766:Insert [Medical Device]
   760   C1883719:Insert [Functional Concept]
   760   C1999230:Provided [Activity]
   760   C2700580:Package [Manufactured Object]
Processing 00000000.tx.110: The R2 value of each standard curve was high, yielding an average result of 0.9954 (2M), 0.9924 (haptoglobin-1), and 0.9939 (S100).  

Phrase: "The R2 value of each standard curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "high,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "yielding"

Phrase: "an average result of 0.9954"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "(2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "0.9924"

Phrase: "(haptoglobin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018595:Haptoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "0.9939"

Phrase: "(S100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441165:S-100 [Immunologic Factor]
  1000   C3273837:S100 [Gene or Genome]
  1000   C3274824:S100 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.111: RESULTS TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Serum samples taken from patients undergoing an osmotic opening of the BBB were analyzed by two-dimensional gel electrophoresis as described under "Experimental Procedures." 

Phrase: "RESULTS TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Serum samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444266:Serum sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "taken from patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]

Phrase: "undergoing"

Phrase: "an osmotic opening of the BBB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0175566:Opening [Spatial Concept]
   753   C1882151:Opening [Spatial Concept]

Phrase: "were"

Phrase: "analyzed by two-dimensional gel electrophoresis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   820   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   790   C1705052:2-Dimensional [Spatial Concept]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0205448:Two [Quantitative Concept]
   753   C0936012:Analyzed [Research Activity]
   753   C1382104:Gel [Substance]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.112: Samples were also analyzed to determine levels of S100, a low molecular weight protein associated with BBB impairment (31). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "also"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "levels of S100,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "a low molecular weight protein"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   902   C0242972:low protein [Therapeutic or Preventive Procedure]
   902   C0748025:low protein [Finding]
   875   C0041667:Low weight [Finding]
   861   C0026385:Molecular Weight [Quantitative Concept]
   812   C0005910:weight [Organism Attribute]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0043100:Weight [Quantitative Concept]
   812   C0205251:low [Qualitative Concept]
   812   C1299352:Low [Qualitative Concept]
   812   C1305866:weight [Diagnostic Procedure]
   812   C1521991:Molecular [Qualitative Concept]
   812   C1550472:low [Idea or Concept]
   812   C1705104:Weight [Idea or Concept]
   741 E C0567416:Molecule [Substance]

Phrase: "associated with BBB impairment"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0005854:BBB [Body Part, Organ, or Organ Component]
   770   C0684336:Impairment [Pathologic Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.113: The results of a typical experiment are shown in Fig. 

Phrase: "The results of a typical experiment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   731   C2825142:Experimental Result [Finding]
           Result
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]

Phrase: "are"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.114: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.115: Note that distinct protein spots appeared increased after BBBD. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that distinct protein spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0015230:spots [Disease or Syndrome]
   827   C0329155:Spot [Fish]
   827   C0848332:Spots [Sign or Symptom]
   827   C1427618:SPOT [Gene or Genome]
   827   C1705203:Spot [Conceptual Entity]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "increased after BBBD."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1511220:BBBD [Therapeutic or Preventive Procedure]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.116: Mass spectrometry revealed that these protein spots corresponded to 2M, a 163-kDa protein with pI 6.0 (NCBI accession number 4557225). 

Phrase: "Mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "these protein spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015230:spots [Disease or Syndrome]
   861   C0329155:Spot [Fish]
   861   C0848332:Spots [Sign or Symptom]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]

Phrase: "corresponded to 2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "a 163-kDa protein with pI 6.0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C0063693:protein pi [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(NCBI accession number 4557225"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   890   C1705803:National Center for Biotechnology Information [Organization]
   836   C0021415:center information [Manufactured Object,Organization]
   812   C1510755:Accession Number [Intellectual Product]
           Accession
   793   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   793   C0205099:Center [Spatial Concept]
   793   C0237753:*Number [Quantitative Concept]
   793   C0449788:Number [Quantitative Concept]
   793   C1533716:Information [Idea or Concept]
   793   C1706078:Accession [Activity]
   793   C3245503:national [Intellectual Product]
   721 E C3242430:informational [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.117: View larger version (34K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.118: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.119: 2M expression is increased after disruption of the blood-brain barrier in vivo. 

Phrase: "2M expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "increased after disruption of the blood-brain barrier"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   822   C1511220:blood-brain barrier disruption [Therapeutic or Preventive Procedure]
   822   C1831732:Blood-Brain Barrier Disruption [Therapeutic or Preventive Procedure]
   800   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
   800   C1305865:Blood-brain barrier [Organ or Tissue Function]
   744   C0005767:Blood [Tissue]
   744   C0005768:blood [Body Substance]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0205217:Increased [Quantitative Concept]
   744   C0229664:Blood [Body Substance]
   744   C0332453:Disruption [Functional Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1706912:BARRIER [Medical Device]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.120: These changes were reflected by a delayed increase in serum levels hours after the procedure. 

Phrase: "These changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "reflected by a delayed increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205421:Delayed [Temporal Concept]
   760   C0442805:Increase [Functional Concept]
   760   C0558058:reflected [Mental Process]
   760   C3272602:Delayed [Qualitative Concept]

Phrase: "in serum levels hours"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]

Phrase: "after the procedure."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.121: A shows the results from a typical experiment performed to compare the electrophoretic appearance of serum proteins before and after BBBD. 

Phrase: "A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the results from a typical experiment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   731   C2825142:Experimental Result [Finding]
           Result
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the electrophoretic appearance of serum proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0550215:Appearance of Serum [Clinical Attribute]
   783   C1278298:Serum appearance [Clinical Attribute]
   753   C0233426:Appearance [Organism Attribute]
   753   C0700364:Appearance [Qualitative Concept]

Phrase: "before"

Phrase: "and after BBBD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1511220:BBBD [Therapeutic or Preventive Procedure]
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.122: Both unchanged (gray arrows) and increased (black arrows) spot areas are indicated. 

Phrase: "Both unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "(gray arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(black arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "spot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0329155:Spot [Fish]
  1000   C1427618:SPOT [Gene or Genome]
  1000   C1705203:Spot [Conceptual Entity]

Phrase: "areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205146:areas [Spatial Concept]
   966 E C0017446:Area [Geographic Area]

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.123: The main change was observed in the high molecular weight region (indicated by the dashed line) corresponding to 2M. 

Phrase: "The main change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "observed in the high molecular weight region"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C1979900:High molecular weight [Qualitative Concept]
   778   C0026385:Molecular Weight [Quantitative Concept]
   774   C0948775:high weight [Sign or Symptom]
   748   C0005910:weight [Organism Attribute]
   748   C0017446:Region [Geographic Area]
   748   C0043100:Weight [Quantitative Concept]
   748   C0205147:Region [Spatial Concept]
   748   C0205250:High [Qualitative Concept]
   748   C1299351:High [Qualitative Concept]
   748   C1305866:weight [Diagnostic Procedure]
   748   C1441672:Observed [Functional Concept]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1705104:Weight [Idea or Concept]
   748   C2700149:HIGH [Intellectual Product]

Phrase: "("

Phrase: "indicated by the dashed line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205132:Line [Spatial Concept]
   760   C1444656:Indicated [Finding]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
   726   C2827624:DASH [Intellectual Product]

Phrase: ")"

Phrase: "corresponding to 2M."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.124: A magnification of the area of interest is shown in the right small panels. 

Phrase: "A magnification of the area of interest"

Phrase: "is"

Phrase: "shown in the right small panels."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205090:Right [Spatial Concept]
   753   C0441833:Panel [Idea or Concept]
   753   C0700321:Small [Quantitative Concept]
   753   C1999270:Panel [Intellectual Product]
   753   C3537156:Panel [Manufactured Object]
   719   C1547282:Show [Intellectual Product]
Processing 00000000.tx.125: Quantification by protein density and statistical analysis (by analysis of variance) are shown in B. 

Phrase: "Quantification by protein density"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantification [Quantitative Concept]

Phrase: "and"

Phrase: "statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "("

Phrase: "by analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of variance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1711260:Variance [Qualitative Concept]
  1000   C2348152:Variance [Quantitative Concept]
   928 E C0205419:Variant [Qualitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown in B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.126: Note that the * indicates a p < 0.05. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the *"

Phrase: "indicates"

Phrase: "a p"

Phrase: "< 0.05."
Processing 00000000.tx.127: 2DE, two-dimensional electrophoresis.  

Phrase: "2DE,"

Phrase: "two-dimensional electrophoresis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   901   C1705052:2-Dimensional [Spatial Concept]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0205448:Two [Quantitative Concept]
   755   C0439534:Dimension [Quantitative Concept]
   755   C1707753:Dimensionality [Spatial Concept]
Processing 00000000.tx.128: The fragments shown in Table I were used for protein identification as described under "Experimental Procedures." 

Phrase: "The fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "shown in Table I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:Table [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "were"

Phrase: "used for protein identification"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0020792:Identification [Mental Process]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205396:Identification [Qualitative Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.129: The results shown in Fig. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.130: 1A refer to blood samples taken from a representative patient before BBBD and 4 h after the procedure. 

Phrase: "1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "refer to blood samples"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0178913:blood samples [Body Substance]
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0205543:refer [Functional Concept]
   770   C0229664:Blood [Body Substance]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "taken from a representative patient"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0030705:*^patient [Patient or Disabled Group]
   760   C1882932:Representative [Activity]
   760   C1883727:Taken [Conceptual Entity]
   726 E C1515187:Take [Health Care Activity]

Phrase: "before BBBD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511220:BBBD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "4 h after the procedure."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.131: Quantitative analysis was performed by determining the number of pixels in gels from six patients. 

Phrase: "Quantitative analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0392762:Quantitative [Quantitative Concept]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by determining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the number of pixels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "from six patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.132: The mean results of these experiments are shown in the bar graph in Fig. 

Phrase: "The mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "results of these experiments"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   777   C2825142:Experimental Result [Finding]
           Result
   770   C0681814:Experiments [Research Activity]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "are"

Phrase: "shown in the bar graph"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0681493:Graph [Intellectual Product]
   760   C2698021:Graph [Conceptual Entity]
   726   C1547282:Show [Intellectual Product]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.133: 1B. 

Phrase: "1B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]
Processing 00000000.tx.134: Only small changes in 2M expression were seen when comparing samples taken minutes after the procedure. 

Phrase: "Only small changes in 2M expression"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   748   C0700321:Small [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "when"

Phrase: "comparing samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "minutes after the procedure."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0439232:minute [Temporal Concept]
   770   C0700321:minute [Quantitative Concept]
   770   C0702093:/minute [Temporal Concept]
   770   C1282918:Minute [Quantitative Concept]
   770   C2347166:Minute [Quantitative Concept]
Processing 00000000.tx.135: However, a significant increase in 2M was observed at 4 h after BBBD. 

Phrase: "However,"

Phrase: "a significant increase in 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed at 4 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]

Phrase: "after BBBD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511220:BBBD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.136: Levels of the spots used as control (haptoglobin-1) remained unchanged during the entire procedure. 

Phrase: "Levels of the spots"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "used as control"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1273517:used [Finding]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "(haptoglobin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018595:Haptoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "remained"

Phrase: "unchanged during the entire procedure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442739:Unchanged [Finding]
   760   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.137: View this table: [in this window] [in a new window]  TABLE I Protein fragments that were used to identify the 2M in serum samples  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE I Protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332255:fragment [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the 2M in serum samples  Fig."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.138: 2 shows quantitative results obtained by radial immunodiffusion technique. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "quantitative results"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C1709795:Quantitative Result [Finding]
   861   C0392762:Quantitative [Quantitative Concept]
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "obtained by radial immunodiffusion technique."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0017231:Immunodiffusion [Laboratory Procedure]
   760   C0442038:Radial [Conceptual Entity]
   760   C0449851:Technique [Functional Concept]
   760   C0920847:Radial [Conceptual Entity]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.139: An increase in 2M comparable to that observed in the two-dimensional gels was discovered (Fig. 2A). 

Phrase: "An increase in 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "comparable to that"

Phrase: "observed in the two-dimensional gels"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1705052:2-Dimensional [Spatial Concept]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0205448:Two [Quantitative Concept]
   753   C1441672:Observed [Functional Concept]
   719 E C1382104:Gel [Substance]

Phrase: "was"

Phrase: "discovered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880355:Discover [Activity]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.140: Levels of haptoglobin-1 (Fig. 2C) remained unchanged during the entire procedure as expected (based on the result shown in Fig. 1B). 

Phrase: "Levels of haptoglobin-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   802   C0456947:Level 1 [Intellectual Product]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: "remained"

Phrase: "unchanged during the entire procedure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442739:Unchanged [Finding]
   760   C2346711:Unchanged [Qualitative Concept]

Phrase: "as expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "("

Phrase: "based on the result"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1274040:Result [Functional Concept]
   770   C1527178:Based [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1705938:Based [Idea or Concept]
   770   C2825142:Result [Finding]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "shown in Fig. 1B"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0349966:Fig [Food]
   770   C0450345:1B [Intellectual Product]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.141: Note that post-BBB disruption samples invariably contained elevated levels of S100 (Fig. 2B; see also Refs. 30, 31, 33, and 50), indicating effective opening of the blood-brain barrier. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that post-BBB disruption samples invariably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0370003:Sample [Substance]
   771   C2347026:Sample [Conceptual Entity]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "elevated levels of S100"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "also Refs. 30,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1425988:REF [Gene or Genome]

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "33,"

Phrase: "and"

Phrase: "50"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "effective opening of the blood-brain barrier."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0175566:Opening [Spatial Concept]
   748   C1882151:Opening [Spatial Concept]
Processing 00000000.tx.142: View larger version (31K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.143: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.144: Radial immunodiffusion analysis demonstrating increased expression of 2M in serum samples. 

Phrase: "Radial immunodiffusion analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "demonstrating"

Phrase: "increased expression of 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in serum samples."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444266:Serum sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.145: The inset shows actual data from a typical experiment. 

Phrase: "The inset"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "actual data from a typical experiment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]
Processing 00000000.tx.146: Protein concentrations were determined by optical evaluation of the diameter of the precipitin ring and extrapolated by reference to a calibration curve according to the manufacturers instruction. 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined by optical evaluation of the diameter of the precipitin ring"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   738   C0032936:precipitin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0220825:Evaluation [Functional Concept]
   738   C0521164:Ring [Spatial Concept]
   738   C1260969:Ring [Medical Device]
   738   C1261322:Evaluation [Health Care Activity]
   738   C1301886:Diameter [Quantitative Concept]
   738   C1705184:Ring [Medical Device]

Phrase: "and"

Phrase: "extrapolated by reference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514811:Reference [Idea or Concept]
   790   C1706462:Reference [Conceptual Entity]

Phrase: "to a calibration curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: "according to the manufacturers instruction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039401:Instruction [Educational Activity]
   861   C0302828:Instruction [Intellectual Product]
   861   C1442085:instruction [Idea or Concept]
Processing 00000000.tx.147: A shows the results obtained from six patients undergoing BBBD. 

Phrase: "A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained from six patients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205452:Six [Quantitative Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "undergoing"

Phrase: "BBBD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511220:BBBD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.148: Note the increase in 2M expression 4 h after BBBD. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the increase in 2M expression 4 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "after BBBD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511220:BBBD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.149: Levels of haptoglobin-1 (C) remained unchanged during the entire procedure. 

Phrase: "Levels of haptoglobin-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   802   C0456947:Level 1 [Intellectual Product]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "remained"

Phrase: "unchanged during the entire procedure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442739:Unchanged [Finding]
   760   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.150: B shows a consistent variation in S100 levels indicating the opening of the blood-brain barrier and the effectiveness of the BBBD procedure. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a consistent variation in S100 levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]

Phrase: "indicating"

Phrase: "the opening of the blood-brain barrier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0175566:Opening [Spatial Concept]
   748   C1882151:Opening [Spatial Concept]

Phrase: "and"

Phrase: "the effectiveness of the BBBD procedure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1280519:Effectiveness [Qualitative Concept]
Processing 00000000.tx.151: Note that the * indicates a p < 0.05, and n.s. means not significantly different from pre-BBBD value. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the *"

Phrase: "indicates"

Phrase: "a p"

Phrase: "< 0.05,"

Phrase: "and"

Phrase: "n.s. means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C1704970:Means [Conceptual Entity]
   793 E C0444504:Mean [Quantitative Concept]
   793 E C2347634:Mean [Quantitative Concept]
   793 E C2348143:Mean [Quantitative Concept]

Phrase: "not significantly different from pre-BBBD value."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.152: MTX, methotrexate; 

Phrase: "MTX,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025677:MTX [Organic Chemical,Pharmacologic Substance]
  1000   C1417487:MTX [Gene or Genome]

Phrase: "methotrexate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025677:Methotrexate [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.153: RID, radial immunodiffusion.  

Phrase: "RID,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073361:RID [Organic Chemical,Pharmacologic Substance]

Phrase: "radial immunodiffusion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0017231:Immunodiffusion [Laboratory Procedure]
   861   C0442038:Radial [Conceptual Entity]
   861   C0920847:Radial [Conceptual Entity]
Processing 00000000.tx.154: Consistent with the data from radial immunodiffusion tests, increased immunoreactivity for 2M was also detected by Western blotting (Fig. 3B). 

Phrase: "Consistent with the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "from radial immunodiffusion tests,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022885:Tests [Laboratory Procedure]
   827   C0392366:Tests [Intellectual Product]
   793 E C0039593:Test [Functional Concept]

Phrase: "increased immunoreactivity for 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "also"

Phrase: "detected by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.155: Quantitative data were obtained by comparing known amounts of 2M standards to experimental results (Fig. 

Phrase: "Quantitative data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "obtained by comparing known amounts of 2M standards"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   742   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0038137:standards [Intellectual Product]
   742   C0175675:Standards [Qualitative Concept]
   742   C0205309:Known [Qualitative Concept]
   742   C1265611:amounts [Quantitative Concept]
   742   C1301820:Obtained [Functional Concept]
   708 E C1442989:Standard [Qualitative Concept]
   708 E C1706701:Obtain [Activity]
   708   C1707455:Compare [Activity]
   708 E C2828392:Standard [Intellectual Product]

Phrase: "to experimental results"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C2825142:Experimental Result [Finding]
           Result
   861   C1517586:Experimental [Qualitative Concept]
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.156: 3A, see "Experimental Procedures" for further details). 

Phrase: "3A,"

Phrase: "see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: "for further details"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1522508:Details [Qualitative Concept]
   827 E C1561567:detail [Functional Concept]

Phrase: ")."
Processing 00000000.tx.157: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.158: 3C shows the mean values obtained from these experiments. 

Phrase: "3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450366:3c [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the mean values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0042295:Values [Qualitative Concept]
   861   C0444504:Mean [Quantitative Concept]
   861   C2347634:Mean [Quantitative Concept]
   861   C2348143:Mean [Quantitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "obtained from these experiments."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.159: View larger version (20K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.160: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.161: Western blot analysis demonstrating increased levels of 2M in blood samples taken from patients undergoing iatrogenic opening of the BBB. 

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "demonstrating"

Phrase: "increased levels of 2M"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0456948:Level 2 [Intellectual Product]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "taken from patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]

Phrase: "undergoing"

Phrase: "iatrogenic opening of the BBB."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0175566:Opening [Spatial Concept]
   760   C1882151:Opening [Spatial Concept]
Processing 00000000.tx.162: Antibodies specific to human 2M were used to quantify expression changes. 

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific to human 2M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "expression changes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.163: Note that quantitative results were obtained by comparison with known amounts of standard protein (A). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that quantitative results"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C1709795:Quantitative Result [Finding]
   861   C0392762:Quantitative [Quantitative Concept]
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained by comparison with known amounts of standard protein (A"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205309:Known [Qualitative Concept]
   739   C1265611:amounts [Quantitative Concept]
   739   C1301820:Obtained [Functional Concept]
   739   C1442989:Standard [Qualitative Concept]
   739   C1707455:Comparison [Activity]
   739   C2828392:Standard [Intellectual Product]
   706 E C1706701:Obtain [Activity]

Phrase: ")."
Processing 00000000.tx.164: B shows increased immunosignal for 2M after BBBD. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "increased immunosignal for 2M"

Phrase: "after BBBD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511220:BBBD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.165: C shows the mean values obtained from six samples: these results were quantitatively similar to those evaluated by radial immunodiffusion (see Fig. 2). 

Phrase: "C"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the mean values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0042295:Values [Qualitative Concept]
   861   C0444504:Mean [Quantitative Concept]
   861   C2347634:Mean [Quantitative Concept]
   861   C2348143:Mean [Quantitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "obtained from six samples"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   802   C1277697:Sample obtained [Finding]
   770   C0205452:Six [Quantitative Concept]
   770   C1301820:Obtained [Functional Concept]
   737   C0370003:Sample [Substance]
   737 E C1706701:Obtain [Activity]
   737   C2347026:Sample [Conceptual Entity]

Phrase: ":"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "quantitatively similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "evaluated by radial immunodiffusion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017231:Immunodiffusion [Laboratory Procedure]
   770   C0220825:Evaluated [Functional Concept]
   770   C0442038:Radial [Conceptual Entity]
   770   C0920847:Radial [Conceptual Entity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.166: The numbers below the protein spots refer to 2M levels expressed in nanograms (*, p < 0.05).  

Phrase: "The numbers below the protein spots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "refer to 2M levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   781   C0456948:Level 2 [Intellectual Product]
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0205543:refer [Functional Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "expressed in nanograms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439212:nanograms [Quantitative Concept]

Phrase: "("

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.167: A bidimensional tissue culture apparatus was used to grow human brain endothelial cells and astrocytes in a variety of configurations aimed at mimicking various stages of BBB formation or failure. 

Phrase: "A bidimensional tissue culture apparatus"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0040284:Tissue culture [Laboratory Procedure]
   812   C0010453:Culture [Idea or Concept]
   812   C0040300:Tissue [Tissue]
   812   C0220814:culture [Functional Concept]
   812   C0243111:apparatus [Manufactured Object]
   812   C0430400:Culture [Laboratory Procedure]
   812   C1547928:Tissue [Intellectual Product]
   812   C1947951:Apparatus [Anatomical Structure]
   812   C2242979:Culture [Laboratory Procedure]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "grow"

Phrase: "human brain endothelial cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   902   C0427861:Human cells [Laboratory or Test Result]
   875   C0596208:brain cells [Cell]
   861   C0225336:Endothelial Cells [Cell]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C0086418:Human [Human]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "astrocytes in a variety of configurations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0004112:Astrocytes [Cell]

Phrase: "aimed at mimicking various stages of BBB formation"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   744   C0005854:BBB [Body Part, Organ, or Organ Component]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   744   C1306673:Stages [Qualitative Concept]
   744   C1522492:Formation [Functional Concept]
   711 E C0205390:Stage [Temporal Concept]
   711 E C1300072:Stage [Clinical Attribute]
   711   C1947946:Aim [Idea or Concept]
   711   C2948600:Aim [Pharmacologic Substance]
   711   C3540471:AIM [Gene or Genome]
   711   C3540472:AIM [Functional Concept]

Phrase: "or"

Phrase: "failure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231174:Failure [Functional Concept]
  1000   C0680095:failure [Individual Behavior]
Processing 00000000.tx.168: The experimental conditions used are illustrated on the left side of Fig. 

Phrase: "The experimental conditions"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "illustrated on the left side of Fig."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0205091:Left side [Spatial Concept]
           Left
   748   C0349966:Fig [Food]
   748   C0441987:Side [Spatial Concept]
   748   C1337208:FIG [Food]
   748   C1552822:left [Functional Concept]
Processing 00000000.tx.169: 4. 

Phrase: "4."
Processing 00000000.tx.170: EC- and AS-conditioned media were obtained from astrocytic and endothelial cultures, respectively. 

Phrase: "EC-"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "AS-conditioned media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "obtained from astrocytic"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0521395:Astrocytic [Body Location or Region]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "endothelial cultures,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "respectively."
Processing 00000000.tx.171: These media were collected regularly every 2 days and stored at -20 C. 

Phrase: "These media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "regularly"

Phrase: "every 2 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442455:2 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -20 C."
Processing 00000000.tx.172: Co-culture of EC and AS were designed to mimic an intact BBB (cells in contact on opposite side of Transwell filters) or BBB failure accompanied by enlarged extracapillary space (EC on filter with glia plated on bottom; intercellular distance was 1 mm). 

Phrase: "Co-culture of EC"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0282547:Co-culture [Laboratory Procedure]
   797   C0007585:cells culture [Laboratory Procedure]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "AS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mimic"

Phrase: "an intact BBB (cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0682538:intact cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "in contact on opposite side of Transwell filters"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0150312:In [Quantitative Concept]
   744   C0332158:contact [Functional Concept]
   744   C0332285:In [Spatial Concept]
   744   C0337611:Contact [Population Group]
   744   C1705415:Contact [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "BBB failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "accompanied by enlarged extracapillary space"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0442800:Enlarged [Qualitative Concept]
   760   C1293134:Enlarged [Therapeutic or Preventive Procedure]
   760   C1883067:Space [Spatial Concept]

Phrase: "(EC on filter"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0225336:Endothelial Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0014257:Endothelial [Tissue]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "with glia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]

Phrase: "plated on bottom"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1511276:Bottom [Spatial Concept]
   790   C1552825:bottom [Idea or Concept]
   756   C0005971:Plate [Medical Device]
   756   C1139930:plate [Medical Device]
   756   C3537155:Plate [Manufactured Object]

Phrase: "; intercellular distance"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0012751:Distance [Quantitative Concept]
   789 E C0443203:Distant [Spatial Concept]

Phrase: "was"

Phrase: "1 mm"

Phrase: ")."
Processing 00000000.tx.173: Patterns of protein release were monitored by two-dimensional gel electrophoresis. 

Phrase: "Patterns of protein release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1317658:Protein pattern [Clinical Attribute]
   770   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "monitored by two-dimensional gel electrophoresis."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   882   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   820   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   790   C1705052:2-Dimensional [Spatial Concept]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0205448:Two [Quantitative Concept]
   753   C1382104:Gel [Substance]
   719   C0030695:monitor [Health Care Activity]
   719   C0150369:monitor [Health Care Activity]
   719   C0181904:Monitor [Medical Device]
   719   C0596972:Monitor [Medical Device]
   719   C1521743:Monitor [Professional or Occupational Group]
   719   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.174: Comparison of gels obtained under different conditions revealed the first appearance of a discrete spot when glia was cultured alone in the presence of EC-conditioned media (Fig. 4). 

Phrase: "Comparison of gels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "obtained under different conditions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C1301820:Obtained [Functional Concept]
   770   C1705242:Different [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
   737 E C1706701:Obtain [Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the first appearance of a discrete spot"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0233426:Appearance [Organism Attribute]
   748   C0700364:Appearance [Qualitative Concept]

Phrase: "when"

Phrase: "glia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]

Phrase: "was"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "alone in the presence of EC-conditioned media"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0205171:Alone [Quantitative Concept]
   742   C0439044:alone [Finding]
   742   C0679994:alone [Group Attribute]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.175: When EC and AS were grown in proximity but not in contact, we noticed an augmentation (in size) of the previous spot and the appearance of two other discrete spots in the immediate proximity. 

Phrase: "When"

Phrase: "EC"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "AS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "grown in proximity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514583:Proximity [Spatial Concept]

Phrase: "but"

Phrase: "not in contact,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332158:contact [Functional Concept]
   827   C0337611:Contact [Population Group]
   827   C1705415:Contact [Idea or Concept]

Phrase: "we"

Phrase: "noticed"

Phrase: "an augmentation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1293122:Augmentation [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "in size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: ")"

Phrase: "of the previous spot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0329155:Spot [Fish]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]

Phrase: "and"

Phrase: "the appearance of two"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233426:Appearance [Organism Attribute]
   770   C0700364:Appearance [Qualitative Concept]

Phrase: "other discrete spots in the immediate proximity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0015230:spots [Disease or Syndrome]
   748   C0329155:Spot [Fish]
   748   C0848332:Spots [Sign or Symptom]
   748   C1427618:SPOT [Gene or Genome]
   748   C1705203:Spot [Conceptual Entity]
Processing 00000000.tx.176: Mass spectroscopy analysis revealed that these changes (see Table II) were due to release of human 2M (NCBI accession number 579592, 163 kDa, pI = 6.04). 

Phrase: "Mass spectroscopy analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0037813:Spectroscopy, Mass [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "these changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table II"

Phrase: ")"

Phrase: "were due to release of human 2M"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0030685:Release [Health Care Activity]
   744   C0086418:Human [Human]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1963578:Release [Therapeutic or Preventive Procedure]
   744   C3146286:Due [Idea or Concept]

Phrase: "(NCBI accession number 579592,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   890   C1705803:National Center for Biotechnology Information [Organization]
   836   C0021415:center information [Manufactured Object,Organization]
   812   C1510755:Accession Number [Intellectual Product]
           Accession
   793   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   793   C0205099:Center [Spatial Concept]
   793   C0237753:*Number [Quantitative Concept]
   793   C0449788:Number [Quantitative Concept]
   793   C1533716:Information [Idea or Concept]
   793   C1706078:Accession [Activity]
   793   C3245503:national [Intellectual Product]
   721 E C3242430:informational [Idea or Concept]

Phrase: "163 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "pI = 6.04"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0429863:PI [Clinical Attribute]
   827   C3537219:PI [Gene or Genome]
   827   C3539772:PI [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.177: Western blotting also demonstrated increased 2M immunoreactivity under these conditions (Fig. 5). 

Phrase: "Western blotting also"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   884 E C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]

Phrase: "demonstrated"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "2M immunoreactivity under these conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.178: To avoid possible and unexpected changes in the experimental parameters, all samples were collected and processed simultaneously after 1 week since the cultures and the co-cultures were completely established. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "and"

Phrase: "unexpected changes in the experimental parameters,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "all samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "simultaneously after 1 week"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332174:/week [Temporal Concept]
   770   C0439230:week [Temporal Concept]
   770   C0521115:simultaneously [Temporal Concept]

Phrase: "since"

Phrase: "the cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "the co-cultures"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0282547:Co-cultures [Laboratory Procedure]
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "established."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.179: View this table: [in this window] [in a new window]  TABLE II Protein fragments were used to identify 2M in media samples from co-culture of AS + EC set to mimic BBB failure (see text for details)   DISCUSSION TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  The main finding from the present work is that the antiproteolytic molecule 2M is increased in serum under conditions of blood-brain barrier failure. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE II Protein fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   844   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "2M in media samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "from co-culture"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0282547:Co-culture [Laboratory Procedure]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "of AS + EC"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0225336:Endothelial Cells [Cell]
   896   C0004112:astrocyte cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mimic"

Phrase: "BBB failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "text for details"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1527021:Text [Intellectual Product]
   790   C1554111:Text [Idea or Concept]
   790   C1705606:Text [Intellectual Product]
   790   C3541382:Text [Intellectual Product]

Phrase: ")"

Phrase: "DISCUSSION TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The main finding from the present work"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037088:Finding [Sign or Symptom]
   748   C0243095:Finding [Finding]
   748   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "that"

Phrase: "the antiproteolytic molecule 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "increased in serum"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0205217:Increased [Quantitative Concept]
   790   C0229671:Serum [Body Substance]
   790   C0442805:Increased [Functional Concept]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "of blood-brain barrier failure."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0231174:Failure [Functional Concept]
   812   C0680095:failure [Individual Behavior]
   756   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
   756   C1305865:Blood-brain barrier [Organ or Tissue Function]
Processing 00000000.tx.180: This was interpreted as an endogenous strategy aimed at counteracting activity of matrix metalloproteinases presumably released by injured BBB cells. 

Phrase: "This"

Phrase: "was"

Phrase: "interpreted as an endogenous strategy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205227:Endogenous [Functional Concept]
   760   C0679199:strategy [Mental Process]
   760   C1285553:interpreted [Functional Concept]

Phrase: "aimed at counteracting activity of matrix metalloproteinases presumably"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   770   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   750   C1150224:metalloproteinase activity [Molecular Function]
   744   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
   744   C1704640:Matrix [Spatial Concept]
   744   C1706515:Matrix [Body Substance]
   711   C1947946:Aim [Idea or Concept]
   711   C2948600:Aim [Pharmacologic Substance]
   711   C3540471:AIM [Gene or Genome]
   711   C3540472:AIM [Functional Concept]

Phrase: "released by injured BBB cells."
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   760   C0005854:BBB [Body Part, Organ, or Organ Component]
   760   C0007634:Cells [Cell]
   760   C0332664:Injured [Functional Concept]
   760   C0391871:Released [Functional Concept]
   760   C1283071:Released [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.181: Post-BBB disruption release of 2M was observed under two different experimental conditions. 

Phrase: "Post-BBB disruption release of 2M"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "observed under two different experimental conditions."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205448:Two [Quantitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1517586:Experimental [Qualitative Concept]
   753   C1705242:Different [Qualitative Concept]
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.182: In one set of experiments, 2M serum levels were elevated hours after iatrogenic opening of the BBB. 

Phrase: "In one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "set of experiments,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0036849:Set [Mental Process]
   790   C0681814:Experiments [Research Activity]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "2M serum levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0456948:2 levels [Intellectual Product]
   812   C0229671:Serum [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "hours after iatrogenic opening of the BBB."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0439227:hours [Temporal Concept]
   714 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.183: In parallel experiments, we documented 2M release in vitro by astrocytes under conditions mimicking BBB failure. 

Phrase: "In parallel experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "in vitro by astrocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]

Phrase: "under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "mimicking"

Phrase: "BBB failure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]
Processing 00000000.tx.184: The implications of this novel finding are 2-fold. 

Phrase: "The implications of this novel finding"

Phrase: "are"

Phrase: "2-fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.185: First, it appears that in addition to tissue inhibitors of metalloproteinases, other endogenous mechanisms exist to limit the extent of matrix remodeling during ischemia or neurodegenerative diseases. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that in addition to tissue inhibitors of metalloproteinases,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   825   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   825   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0040300:Tissue [Tissue]
   744   C0243077:inhibitors [Chemical Viewed Functionally]
   744   C1547928:Tissue [Intellectual Product]
   744   C1883712:Addition [Functional Concept]
   734   C1152589:metalloproteinase inhibitor [Molecular Function]
   711 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "other endogenous mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "limit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "the extent of matrix remodeling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "during ischemia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022116:Ischaemia [Disease or Syndrome]
   928 E C0475224:Ischaemic [Functional Concept]

Phrase: "or"

Phrase: "neurodegenerative diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.186: Second, enhancing 2M expression may be a useful strategy against MMP-mediated degradation of the extracellular matrix. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "enhancing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "2M expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "a useful strategy against MMP-mediated degradation of the extracellular matrix."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0679199:strategy [Mental Process]
Processing 00000000.tx.187: Temporal Patterns and Molecular Mechanisms of 2M Release While most pictorials represent the brain endothelium as a static, tight-junctioned barrier, the BBB has been repeatedly shown to be a dynamic organ that readily responds and adapts to external stimuli (3437). 

Phrase: "Temporal Patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "Molecular Mechanisms of 2M Release"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "While"

Phrase: "most pictorials"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the brain endothelium as a static, tight-junctioned barrier,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0014257:Endothelium [Tissue]

Phrase: "the BBB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005854:BBB [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "been"

Phrase: "repeatedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205341:Repeatedly [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a dynamic organ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178784:Organ [Body Part, Organ, or Organ Component]

Phrase: "that readily"

Phrase: "responds"

Phrase: "and"

Phrase: "adapts to external stimuli"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205101:External [Spatial Concept]
   770   C0234402:Stimuli [Phenomenon or Process]
   770   C2937289:adapt [Organic Chemical]

Phrase: "(3437"

Phrase: ")."
Processing 00000000.tx.188: So far, several mediators of BBB maintenance or failure have been described, but the exact molecular and cellular mechanisms involved in endothelium-mediated central nervous system homeostasis are virtually unknown. 

Phrase: "So"

Phrase: "far,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "several mediators of BBB maintenance"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   726 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231174:Failure [Functional Concept]
  1000   C0680095:failure [Individual Behavior]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ","

Phrase: "but"

Phrase: "the exact molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "cellular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in endothelium-mediated central nervous system homeostasis"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   800   C0927232:Central Nervous System [Body System]
   800   C1269563:Central nervous system [Body System]
   770   C0027763:Nervous System [Body System]
   770   C0422837:NERVOUS SYSTEM [Finding]
   770   C1269560:Nervous system [Body System]
   767   C0449915:System involved [Spatial Concept]
   744   C0014257:Endothelium [Tissue]
   744   C0019868:Homeostasis [Biologic Function]
   744   C0027769:Nervous [Sign or Symptom]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0205099:Central [Spatial Concept]
   744   C0449913:System [Functional Concept]
   744   C0599851:Nervous [Functional Concept]
   744   C1314939:Involved [Functional Concept]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   744   C1879652:Central - [Laboratory Procedure]
   715 E C0205494:Neurologic [Qualitative Concept]

Phrase: "are"

Phrase: "virtually unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.189: Recent evidence has shown that MMPs are involved in the enzymatic digestion of the extracellular matrix (8, 10, 39). 

Phrase: "Recent evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that MMPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0623362:MMPs [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C0919336:MMP [Gene or Genome]

Phrase: "are"

Phrase: "involved in the enzymatic digestion of the extracellular matrix"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0015350:Extracellular Matrix [Tissue]
   742   C0012238:Digestion [Organism Function]
   742   C0521119:Extracellular [Cell Component]
   742   C1314939:Involved [Functional Concept]
   742   C1704640:Matrix [Spatial Concept]
   742   C1706515:Matrix [Body Substance]
   742   C2349986:Digestion [Research Activity]

Phrase: "(8,"

Phrase: "10,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.190: Interestingly serum levels of MMP-9 correlate with hemorrhagic conversion after thrombolytic therapy for acute stroke (40), suggesting that BBB damage may play a role in tissue plasminogen activator toxicity (4143). 

Phrase: "Interestingly serum levels of MMP-9"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0229671:Serum [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "correlate with hemorrhagic conversion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0333275:Haemorrhagic [Qualitative Concept]
   770   C0439836:Conversion [Functional Concept]

Phrase: "after thrombolytic therapy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0040044:Thrombolytic Therapy [Therapeutic or Preventive Procedure]
   861   C0016018:Thrombolytic [Pharmacologic Substance]
   861   C0039798:therapy [Functional Concept]
   861   C0087111:Therapy [Therapeutic or Preventive Procedure]
   861   C0520997:Thrombolytic [Clinical Attribute]
   861   C1363945:Therapy [Finding]

Phrase: "for acute stroke"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751956:Stroke, Acute [Disease or Syndrome]
   861   C0038454:Stroke [Disease or Syndrome]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that BBB damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in tissue plasminogen activator toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "(4143"

Phrase: ")."
Processing 00000000.tx.191: The findings presented here demonstrate that, in addition to potentially deleterious molecular events, antiproteolytic molecules such as 2M are also produced. 

Phrase: "The findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "demonstrate"

Phrase: "that,"

Phrase: "in addition to potentially deleterious molecular events,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441471:Events [Event]
   812   C3541888:Events [Classification]

Phrase: "antiproteolytic molecules such as 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0567416:molecules [Substance]

Phrase: "are"

Phrase: "also"

Phrase: "produced."
Processing 00000000.tx.192: It is not clear whether these are synthesized ex novo in direct response to injury or following activation of metalloproteinases. 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "these"

Phrase: "are"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "ex novo in direct response"

Phrase: "to injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "or"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "activation of metalloproteinases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]
Processing 00000000.tx.193: Alternatively it is possible that the ubiquitous 2M simply accumulates in blood after injury, after being recalled, or after leaking from the central nervous system. 

Phrase: "Alternatively"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the ubiquitous 2M simply"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "accumulates in blood"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0005767:Blood [Tissue]
   790   C0005768:blood [Body Substance]
   790   C0229664:Blood [Body Substance]
   718 E C0333275:Bloody [Qualitative Concept]
   706 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   706 E C0392895:Bloods [Population Group]
   706 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   706 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "after injury,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]

Phrase: "after"

Phrase: "being"

Phrase: "recalled"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0034770:Recall [Mental Process]
   966   C1705180:Recall [Governmental or Regulatory Activity]
   966   C2361119:Recall [Clinical Attribute]

Phrase: ","

Phrase: "or after leaking"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0332234:Leaking [Functional Concept]
   756 E C1608322:Leak NOS [Finding]
   756 E C1881366:LEAK [Phenomenon or Process]

Phrase: "from the central nervous system."
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.194: It has been suggested that elevated CSF levels of 2M indicate damage to the blood-to-CSF barrier (44). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that elevated CSF levels of 2M"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0007806:Cerebrospinal Fluid [Body Substance]
   770   C0007807:cerebrospinal fluid [Functional Concept]
   750   C0456948:Level 2 [Intellectual Product]
   744   C0005889:FLUID [Body Substance]
   744   C0302908:fluid [Substance]
   744   C0441889:Levels [Qualitative Concept]
   744   C0444611:Fluid [Qualitative Concept]
   744   C1704353:Fluid [Substance]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "indicate"

Phrase: "damage to the blood-to-CSF barrier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0010957:Damage [Injury or Poisoning]
   744   C1883709:Damage [Functional Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.195: Thus, it was hypothesized that, during neuroinflammation, 2M extravasates from blood to CSF due to the favorable gradient between blood and CSF and a damaged protein-permeant BBB. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "was"

Phrase: "hypothesized"

Phrase: "that,"

Phrase: "during neuroinflammation,"

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "extravasates from blood"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0005767:Blood [Tissue]
   790   C0005768:blood [Body Substance]
   790   C0229664:Blood [Body Substance]
   718 E C0333275:Bloody [Qualitative Concept]
   706 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   706 E C0392895:Bloods [Population Group]
   706 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   706 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "to CSF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "due to the favorable gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439182:% gradient [Quantitative Concept]
   861   C0812409:Gradient [Quantitative Concept]

Phrase: "between blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "CSF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "and"

Phrase: "a damaged protein-permeant BBB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0005854:BBB [Body Part, Organ, or Organ Component]
Processing 00000000.tx.196: Our in vivo experiments did not address this issue directly since CSF samples were for obvious reasons not available. 

Phrase: "Our in vivo experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this issue directly since CSF samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C1292530:Cerebrospinal fluid sample [Body Substance]
   810   C0438734:Fluid sample [Body Substance]
   766   C0370003:Sample [Substance]
   766   C2347026:Sample [Conceptual Entity]

Phrase: "were for obvious reasons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392360:reasons [Idea or Concept]

Phrase: "not available."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548671:Not available [Idea or Concept]
   861   C0470187:Available [Functional Concept]
Processing 00000000.tx.197: However, comparisons of a time course of 2M level with changes in the putative indicator of BBB damage S100 suggest that the observed 2M increase was a consequence of BBBD rather than a concomitant event. 

Phrase: "However,"

Phrase: "comparisons of a time course of 2M level"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1707455:Comparison [Activity]

Phrase: "with changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in the putative indicator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   861   C1235732:Indicator [Bird]
   861   C1522602:Indicator [Functional Concept]

Phrase: "of BBB damage S100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1441165:S-100 [Immunologic Factor]
   827   C3273837:S100 [Gene or Genome]
   827   C3274824:S100 [Gene or Genome]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the observed 2M increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "a consequence of BBBD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "rather than"

Phrase: "a concomitant event."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]
Processing 00000000.tx.198: In fact, 2M levels were significantly increased only after the initial, rapid surge of S100 (31, 33). 

Phrase: "In fact,"

Phrase: "2M levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   913   C0456948:2 levels [Intellectual Product]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "only after the initial, rapid surge of S100"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0205171:Only [Quantitative Concept]
   744   C0205265:Initial [Temporal Concept]
   744   C0439831:Rapid [Qualitative Concept]
   744   C1279901:Initial [Qualitative Concept]
   744   C1441165:S-100 [Immunologic Factor]
   744   C1555582:Initial [Idea or Concept]
   744   C1705685:INITIAL [Functional Concept]
   744   C1720467:Only [Intellectual Product]
   744   C3273837:S100 [Gene or Genome]
   744   C3274824:S100 [Gene or Genome]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.199: Thus the increased levels of 2M after BBB disruption may be a reaction to proinflammatory changes that occur after the insult to the brain endothelium. 

Phrase: "Thus"

Phrase: "the increased levels of 2M"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0456948:Level 2 [Intellectual Product]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "after BBB disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332453:Disruption [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "a reaction to proinflammatory changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]

Phrase: "that"

Phrase: "occur after the insult"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "to the brain endothelium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014257:Endothelium [Tissue]
Processing 00000000.tx.200: Cellular Origin of 2M Under normal conditions, the plasma level of 2M exceeds the CSF level of 2M by a factor of >1,000 (4547). 

Phrase: "Cellular Origin of 2M"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0079946:origin [Classification]
   760   C0439659:Origin [Temporal Concept]
   760   C1550512:origin [Intellectual Product]
   704 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   704 E C0314603:Genetic [Functional Concept]

Phrase: "Under normal conditions,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   983   C0231162:Normal condition [Finding]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the plasma level of 2M"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0456948:Level 2 [Intellectual Product]
   753   C0032105:Plasma [Body Substance]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "exceeds"

Phrase: "the CSF level of 2M"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0007806:Cerebrospinal Fluid [Body Substance]
   778   C0007807:cerebrospinal fluid [Functional Concept]
   774   C0456948:Level 2 [Intellectual Product]
   748   C0005889:FLUID [Body Substance]
   748   C0302908:fluid [Substance]
   748   C0441889:Level [Qualitative Concept]
   748   C0444611:Fluid [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C1704353:Fluid [Substance]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "by a factor of >1,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "(4547"

Phrase: ")."
Processing 00000000.tx.201: Thus, if the BBB is permeable to macromolecules (for example after osmotic disruption of endothelial tight junctions) 2M levels can be elevated in the CSF but not in the plasma. 

Phrase: "Thus,"

Phrase: "if"

Phrase: "the BBB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005854:BBB [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "permeable to macromolecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205326:Permeable [Functional Concept]
   718 E C0031164:Permeabilities [Natural Phenomenon or Process]

Phrase: "("

Phrase: "for example"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "after osmotic disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332453:Disruption [Functional Concept]

Phrase: "of endothelial tight junctions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0242358:Tight Junctions [Body Space or Junction]
   867 E C2984287:Tight junction [Functional Concept]
   827   C0439816:Tight [Qualitative Concept]
   827   C0453911:tight [Manufactured Object]
   793   C0205144:Junction [Spatial Concept]
   793   C1706311:Junction [Medical Device]

Phrase: ")"

Phrase: "2M levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   913   C0456948:2 levels [Intellectual Product]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "can"

Phrase: "be"

Phrase: "elevated in the CSF"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007806:Cerebrospinal Fluid [Body Substance]
   806   C0007807:cerebrospinal fluid [Functional Concept]
   760   C0005889:FLUID [Body Substance]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0302908:fluid [Substance]
   760   C0444611:Fluid [Qualitative Concept]
   760   C1704353:Fluid [Substance]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "but"

Phrase: "not in the plasma."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032105:Plasma [Body Substance]
   770   C1518422:Not [Functional Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
Processing 00000000.tx.202: However, we observed a marked increase in serum 2M following osmotic opening of the BBB suggesting that the source of 2M may be peripheral. 

Phrase: "However,"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a marked increase in serum 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "osmotic opening of the BBB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0175566:Opening [Spatial Concept]
   760   C1882151:Opening [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the source of 2M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "peripheral."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205100:Peripheral [Spatial Concept]
Processing 00000000.tx.203: In vitro, in contrast, we observed a detectable increase in 2M presumably released by glia. 

Phrase: "In vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "in contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a detectable increase in 2M presumably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "released by glia."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0027836:Glia [Cell]
   790   C0391871:Released [Functional Concept]
   790   C1087003:Glia [Plant]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.204: This latter hypothesis is supported by the fact that 2M was found under the condition where glia was cultured alone in the presence of EC-conditioned media. 

Phrase: "This latter hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "supported by the fact"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "that 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "found under the condition where glia"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0012634:condition [Disease or Syndrome]
   753   C0027836:Glia [Cell]
   753   C0150312:Found [Quantitative Concept]
   753   C0348080:Condition [Qualitative Concept]
   753   C1087003:Glia [Plant]
   753   C1705253:Condition [Conceptual Entity]
   719 E C0243095:Find [Finding]

Phrase: "was"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "alone in the presence of EC-conditioned media."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0205171:Alone [Quantitative Concept]
   742   C0439044:alone [Finding]
   742   C0679994:alone [Group Attribute]
Processing 00000000.tx.205: Under the condition where EC and AS were grown in proximity but not in contact, we noticed an increased release of 2M suggesting the endothelium modulates 2M release by glia. 

Phrase: "Under the condition where EC"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0225336:Endothelial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "AS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "grown in proximity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514583:Proximity [Spatial Concept]

Phrase: "but"

Phrase: "not in contact,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332158:contact [Functional Concept]
   827   C0337611:Contact [Population Group]
   827   C1705415:Contact [Idea or Concept]

Phrase: "we"

Phrase: "noticed"

Phrase: "an increased release of 2M"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the endothelium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014257:Endothelium [Tissue]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "2M release by glia."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.206: Under this latter condition, the appearance of three spots at the same molecular weight as the 2M band but positioned at slightly different pIs suggests that different isoforms of 2M were also released. 

Phrase: "Under this latter condition,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the appearance of three spots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0233426:Appearance [Organism Attribute]
   760   C0700364:Appearance [Qualitative Concept]

Phrase: "at the same molecular weight"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0026385:Molecular Weight [Quantitative Concept]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1521991:Molecular [Qualitative Concept]
   827   C1705104:Weight [Idea or Concept]
   755 E C0567416:Molecule [Substance]

Phrase: "as the 2M band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "but"

Phrase: "positioned at slightly different pIs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0750482:Slightly [Idea or Concept]
   760   C1413284:PIS [Gene or Genome]
   760   C1705242:Different [Qualitative Concept]
   726   C0733755:Position [Spatial Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that different isoforms of 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "also"

Phrase: "released."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.207: By mass spectrometry and Western blot analysis, they were demonstrated to be the same protein. 

Phrase: "By mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "Western blot analysis,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "they"

Phrase: "were"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the same protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.208: The results obtained from in vivo and in vitro experiments are not necessarily in contradiction since it is possible that 2M is released systemically and by perivascular glia after osmotic challenge. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained from in vivo"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1515655:In Vivo [Spatial Concept]
           vivo
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "in vitro experiments"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "are"

Phrase: "not necessarily in contradiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1518422:Not [Functional Concept]

Phrase: "since"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "systemically"

Phrase: "and by perivascular glia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0027836:Glia [Cell]
   770   C0442165:Perivascular [Spatial Concept]
   770   C1087003:Glia [Plant]
   770   C1515981:And [Idea or Concept]

Phrase: "after osmotic challenge."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.209: If this was the case, what are the initial triggers and critical cellular substrates of 2M release? 

Phrase: "If"

Phrase: "this"

Phrase: "was"

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "what"

Phrase: "are"

Phrase: "the initial triggers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032930:triggers [Clinical Attribute]
   827 E C1444748:Trigger [Qualitative Concept]

Phrase: "and"

Phrase: "critical cellular substrates of 2M release?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.210: 2M is primarily synthesized by liver cells. 

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "primarily"

Phrase: "synthesized by liver cells."
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   833   C0227525:liver cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C1883254:Synthesized [Activity]
   770   C2346688:LIVER [Food]
   770   C3282337:Cells [Cell]
   761 E C2697585:Hepatocellular [Qualitative Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   715 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.211: It has been suggested that 2M can also be synthesized by astrocytes (48), which is consistent with our current findings. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "synthesized by astrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004112:Astrocytes [Cell]
   790   C1883254:Synthesized [Activity]

Phrase: "(48"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "consistent with our current findings."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
   745   C0332529:Consistency finding [Qualitative Concept]
Processing 00000000.tx.212: It may be argued that the hyperosmotic medium itself could cause 2M release. 

Phrase: "It"

Phrase: "may"

Phrase: "be"

Phrase: "argued"

Phrase: "that"

Phrase: "the hyperosmotic medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "itself"

Phrase: "could"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "2M release."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.213: However, this seems unlikely since hyperosmotic mannitol failed to cause significant release of 2M from human epithelial cells (49). 

Phrase: "However,"

Phrase: "this"

Phrase: "seems"

Phrase: "unlikely since hyperosmotic mannitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "significant release of 2M"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from human epithelial cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0427861:Human cells [Laboratory or Test Result]
   901   C0014597:Epithelial Cells [Cell]
   901   C1273342:Epithelial Cells [Laboratory Procedure]
   827   C0007634:Cells [Cell]
   827   C0221908:Epithelial [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.214: In addition to liver cells and astroglia, blood cells may also produce 2M (50). 

Phrase: "In addition to liver cells"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0227525:liver cells [Cell]
   928 E C2697585:Hepatocellular [Qualitative Concept]
   861   C0007634:Cells [Cell]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "astroglia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astroglia [Cell]

Phrase: "blood cells"
Meta Candidates (Total=17; Excluded=11; Pruned=0; Remaining=6)
  1000   C0005773:Blood Cells [Cell]
   955 E C2328697:Hemal cell [Cell]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0007634:Cells [Cell]
   861   C0229664:Blood [Body Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "may"

Phrase: "also"

Phrase: "produce"

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.215: Given the fact that the observed increases in serum are hard to reconcile exclusively with increased synthesis in brain, it appears that more than one cell type is involved. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the fact"

Phrase: "that"

Phrase: "the observed increases in serum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "are"

Phrase: "hard to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018599:Hard [Qualitative Concept]

Phrase: "reconcile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1960278:RECONCILE [Organic Chemical,Pharmacologic Substance]

Phrase: "exclusively with increased synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205217:Increased [Quantitative Concept]
   770   C0220781:synthesis [Biologic Function]
   770   C0442805:Increased [Functional Concept]
   770   C1883254:Synthesis [Activity]

Phrase: "in brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that more than one cell type"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0007634:Cell Type [Cell]
           Cell
   790   C0449475:cell type [Intellectual Product]
   753   C0205447:One [Quantitative Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1547052:*Type [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.216: The critical origin of 2M supply needs to be determined in the future. 

Phrase: "The critical origin of 2M supply"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0079946:origin [Classification]
   748   C0439659:Origin [Temporal Concept]
   748   C1550512:origin [Intellectual Product]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined in the future."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016884:Future [Temporal Concept]
Processing 00000000.tx.217: Two-dimensional Gel Plasma Electrophoresis: a Proteomic Tool to Study Peripheral Markers of Neurological Disorders Modern neurodiagnostic techniques use imaging, ultrasound, direct sampling of cerebrospinal fluid, or Doppler techniques to gain insight in brain (dys)function. 

Phrase: "Two-dimensional Gel Plasma Electrophoresis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   933   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   911   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   853   C0596607:Gel Electrophoresis [Laboratory Procedure]
   804   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: ":"

Phrase: "a Proteomic Tool to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0336791:Tool [Manufactured Object]
   827   C2827396:Tool [Manufactured Object]

Phrase: "Study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "Peripheral Markers of Neurological Disorders Modern neurodiagnostic techniques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0005516:Marker [Clinical Attribute]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: ","

Phrase: "ultrasound,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041618:Ultrasound [Diagnostic Procedure]
  1000   C0041621:ultrasound [Natural Phenomenon or Process]
  1000   C0220934:ultrasound [Functional Concept]
  1000   C1456803:Ultrasound [Natural Phenomenon or Process]
  1000   C1875843:ULTRASOUND [Medical Device]

Phrase: "direct sampling of cerebrospinal fluid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441621:Sampling [Diagnostic Procedure]
   760   C0870078:Sampling [Idea or Concept]

Phrase: "or"

Phrase: "Doppler"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554756:Doppler [Diagnostic Procedure]

Phrase: "techniques to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "insight in brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0233820:Insight [Mental Process]

Phrase: "(dys)function."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0013364:DYS [Congenital Abnormality,Disease or Syndrome]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.218: An array of blood tests would be ideal to examine changes occurring in the brain parenchyma. 

Phrase: "An array of blood tests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510941:Array [Spatial Concept]

Phrase: "would"

Phrase: "be"

Phrase: "ideal to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512612:Ideal [Qualitative Concept]

Phrase: "examine"

Phrase: "changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "occurring in the brain parenchyma."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0933845:Parenchyma [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   726   C1709305:Occur [Activity]
   726   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.219: This is hampered by the presence of the BBB that effectively separates the brain from blood and vice versa (31, 33, 51). 

Phrase: "This"

Phrase: "is"

Phrase: "hampered by the presence of the BBB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0005854:BBB [Body Part, Organ, or Organ Component]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "that effectively"

Phrase: "separates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443299:Separate [Spatial Concept]
  1000   C1881713:SEPARATES [Phenomenon or Process]

Phrase: "the brain from blood"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "vice versa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814670:vice [Idea or Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "33,"

Phrase: "51"

Phrase: ")."
Processing 00000000.tx.220: However, evidence suggests that the blood-brain barrier is breached in a variety of neurological disorders, allowing communication between the periphery and central nervous system. 

Phrase: "However,"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "is"

Phrase: "breached in a variety of neurological disorders,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0027765:Neurological Disorders [Disease or Syndrome]
   748   C0012634:Disorders [Disease or Syndrome]
   748   C0205494:Neurological [Qualitative Concept]
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]
   748   C2707261:Neurological [Clinical Attribute]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "communication between the periphery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0009452:Communication [Social Behavior]

Phrase: "and"

Phrase: "central nervous system."
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.221: Thus, diagnosis of diseases may be possible by peripheral blood analysis and routinely used in ischemic heart attack. 

Phrase: "Thus,"

Phrase: "diagnosis of diseases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011900:Diagnosis [Finding]
   790   C1704338:diagnosis [Qualitative Concept]
   790   C1704656:DIAGNOSIS [Research Activity]

Phrase: "may"

Phrase: "be"

Phrase: "possible by peripheral blood analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332149:Possible [Qualitative Concept]
   760   C1705910:Possible [Qualitative Concept]
   760   C2362652:Possible [Qualitative Concept]

Phrase: "and"

Phrase: "routinely"

Phrase: "used in ischemic heart attack."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0027051:Heart attack [Disease or Syndrome]
   797   C0745413:ischemic attack [Disease or Syndrome]
   760   C0018787:Heart [Body Part, Organ, or Organ Component]
   760   C0277793:Attack, NOS [Temporal Concept]
   760   C0475224:Ischaemic [Functional Concept]
   760   C1261512:attack [Social Behavior]
   760   C1273517:used [Finding]
   760   C1281570:Heart [Body Part, Organ, or Organ Component]
   760   C1304680:Attack [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.222: Creatine phosphokinase and lactate dehydrogenase are reliable markers of myocardiac infarct. 

Phrase: "Creatine phosphokinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010287:Creatine Phosphokinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010286:Creatine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0031727:Phosphokinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "lactate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "are"

Phrase: "reliable markers of myocardiac infarct."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.223: A number of putative markers of Alzheimers dementia consist of proteins or protein fragments that are mutated in the disease condition (52). 

Phrase: "A number of putative markers of Alzheimers dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "consist of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332529:CONSIST [Qualitative Concept]

Phrase: "or"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332255:fragment [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "mutated in the disease condition"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0012634:Disease [Disease or Syndrome]
           condition
   760   C0348080:Condition [Qualitative Concept]
   760   C1705253:Condition [Conceptual Entity]
   760   C1705285:Mutated [Cell or Molecular Dysfunction]
   726 E C1513776:Mutate [Genetic Function]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.224: A mutated form of 2M has been suggested to participate in a neuropathogenic pathway leading to Alzheimers dementia (53). 

Phrase: "A mutated form of 2M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "participate in a neuropathogenic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "leading to Alzheimers dementia"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0002395:alzheimers dementia [Disease or Syndrome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0332152:Leading [Temporal Concept]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.225: Thus, detection of 2M in serum may afford a routine test for early detection of presenile dementia. 

Phrase: "Thus,"

Phrase: "detection of 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "may"

Phrase: "afford"

Phrase: "a routine test for early detection of presenile dementia."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0438925:Dementia test [Diagnostic Procedure]
   742   C0022885:Test [Laboratory Procedure]
   742   C0039593:Test [Functional Concept]
   742   C0392366:test [Intellectual Product]
Processing 00000000.tx.226: We have previously shown the value of the proteomic approach to discovery of markers of BBB damage (31, 33, 51). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the value of the proteomic approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522609:Value [Quantitative Concept]

Phrase: "to discovery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880355:Discovery [Activity]

Phrase: "of markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0005516:Marker [Clinical Attribute]

Phrase: "of BBB damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "33,"

Phrase: "51"

Phrase: ")."
Processing 00000000.tx.227: Limitations of this approach include the relatively poor resolution of high molecular weight signals in serum due to the preponderance of albumin expression, the equally poor resolution of proteins present in low abundance, and the relatively high cost of this technique. 

Phrase: "Limitations of this approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449295:limitations [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the relatively poor resolution of high molecular weight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1719039:High resolution [Laboratory Procedure]
   744   C1514893:Resolution [Idea or Concept]
   744   C1706463:Resolution [Quantitative Concept]
   744   C2699488:Resolution [Conceptual Entity]

Phrase: "signals in serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0229671:Serum [Body Substance]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]
   790   C1710082:Signal [Phenomenon or Process]

Phrase: "due to the preponderance"

Phrase: "of albumin expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the equally poor resolution of proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514893:Resolution [Idea or Concept]
   753   C1706463:Resolution [Quantitative Concept]
   753   C2699488:Resolution [Conceptual Entity]

Phrase: "present in low abundance,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0150312:Present [Quantitative Concept]
   770   C0205251:low [Qualitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   770   C2346714:Abundance [Qualitative Concept]

Phrase: "and"

Phrase: "the relatively high cost of this technique."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Cost [Quantitative Concept]
   748   C0220812:cost [Quantitative Concept]
Processing 00000000.tx.228: However, two-dimensional gel electrophoresis has the immense advantage of allowing rapid identification of proteins by mass spectroscopy. 

Phrase: "However,"

Phrase: "two-dimensional gel electrophoresis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0013860:2 Dimensional Gel Electrophoresis [Laboratory Procedure]
   923   C0678632:two-dimensional electrophoresis [Laboratory Procedure]
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   861   C1705052:2-Dimensional [Spatial Concept]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0205448:Two [Quantitative Concept]
   812   C1382104:Gel [Substance]
   741   C0439534:Dimension [Quantitative Concept]
   741   C1707753:Dimensionality [Spatial Concept]

Phrase: "has"

Phrase: "the immense advantage of allowing rapid identification of proteins"

Phrase: "by mass spectroscopy."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0037813:Spectroscopy, Mass [Laboratory Procedure]
   861   C0037812:spectroscopy [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C2713504:Spectroscopy [Occupation or Discipline]
   861   C2984732:SPECTROSCOPY [Functional Concept]
   861   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.229: This approach has in the past allowed the evaluation of 2M changes occurring during aging (38), further demonstrating that at least for selected high molecular weight proteins this approach is feasible. 

Phrase: "This approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "has in the past"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1444637:Past [Temporal Concept]
   770   C3539897:Has [Qualitative Concept]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "the evaluation of 2M changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "occurring during aging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001811:Ageing [Organism Function]
   756   C1709305:Occur [Activity]
   756   C2745955:OCCUR [Temporal Concept]

Phrase: "(38"

Phrase: ")"

Phrase: ","

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "demonstrating"

Phrase: "that at least"

Phrase: "for selected high molecular weight proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1979900:High molecular weight [Qualitative Concept]

Phrase: "this approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "is"

Phrase: "feasible."
Processing 00000000.tx.230: Experiments are on-going to explore the possibility of using this approach to measure mutated, polymorphic forms of this protein in Alzheimers dementia and other disorders. 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "are"

Phrase: "on-going to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720176:On [Functional Concept]
   827   C1720294:On [Intellectual Product]

Phrase: "explore"

Phrase: "the possibility of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   718   C0332149:Possible [Qualitative Concept]
   718   C1705910:Possible [Qualitative Concept]
   718   C2362652:Possible [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this approach to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "mutated, polymorphic forms of this protein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "in Alzheimers dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0002395:alzheimers dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "other disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.231: In conclusion, we demonstrated that a rapid increase of 2M in serum occurs in patients after BBBD. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "a rapid increase of 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "occurs in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "after BBBD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511220:BBBD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.232: Moreover we demonstrated that in vitro BBB failure mimicking this condition up-regulates 2M release from AS. 

Phrase: "Moreover"

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that in vitro BBB failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0231174:Failure [Functional Concept]
   812   C0680095:failure [Individual Behavior]

Phrase: "mimicking"

Phrase: "this condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "up-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "2M release from AS."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.233: Although MMP activity levels need to be studied in these experimental paradigms, our data suggest that 2M may constitute an endogenous counterbalancing mechanism against BBB failure.  

Phrase: "Although"

Phrase: "MMP activity levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0683317:activity levels [Finding]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "studied in these experimental paradigms,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C0681814:experimental study [Research Activity]
   760   C0681797:paradigms [Research Activity]
   760   C1517586:Experimental [Qualitative Concept]
   726   C0557651:Study [Manufactured Object]
   726   C2603343:Study [Research Activity]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "may"

Phrase: "constitute"

Phrase: "an endogenous counterbalancing mechanism against BBB failure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.234: ACKNOWLEDGMENTS  The kits used to measure S100 were a kind gift from Sangtec Medical (Bromma, Sweden).  

Phrase: "ACKNOWLEDGMENTS"

Phrase: "The kits"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1690540:Kits [Qualitative Concept]
   966 E C0812225:KIT [Medical Device]
   966 E C1150635:KIT [Molecular Function]
   966 E C1705212:Kit [Medical Device]
   966 E C1705213:KIT [Medical Device]
   966 E C3273202:Kit [Manufactured Object]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "S100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441165:S-100 [Immunologic Factor]
  1000   C3273837:S100 [Gene or Genome]
  1000   C3274824:S100 [Gene or Genome]

Phrase: "were"

Phrase: "a kind gift from Sangtec"

Phrase: "Medical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205476:Medical [Functional Concept]

Phrase: "(Bromma,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")."
Processing 00000000.tx.235: FOOTNOTES  Received, November 26, 2002, and in revised form, April 10, 2003. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: ","

Phrase: "November 26,"

Phrase: "2002,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "April 10,"

Phrase: "2003."
Processing 00000000.tx.236: Published, MCP Papers in Press, April 24, 2003, DOI 10.1074/mcp.M200077-MCP200 1 The abbreviations used are: BBB, blood-brain barrier; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "MCP Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "April 24,"

Phrase: "2003,"

Phrase: "DOI 10.1074/mcp.M200077-MCP200 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C2348291:DOI [Classification]
   795   C3540820:MCP [Gene or Genome]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "BBB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005854:BBB [Body Part, Organ, or Organ Component]

Phrase: "blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.237: MMP, matrix metalloproteinase; 

Phrase: "MMP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919336:MMP [Gene or Genome]

Phrase: "matrix metalloproteinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: ";"
Processing 00000000.tx.238: BBBD, BBB disruption by hyperosmotic mannitol; 

Phrase: "BBBD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511220:BBBD [Therapeutic or Preventive Procedure]

Phrase: "BBB disruption by hyperosmotic mannitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: ";"
Processing 00000000.tx.239: 2M, 2-macroglobulin; 

Phrase: "2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "2-macroglobulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.240: AS, astrocytes; 

Phrase: "AS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: ";"
Processing 00000000.tx.241: EC, endothelial cells; 

Phrase: "EC,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.242: Chaps, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; 

Phrase: "Chaps,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   966 E C0950540:chap [Therapeutic or Preventive Procedure]

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "["

Phrase: "(3-cholamidopropyl"

Phrase: ")"

Phrase: "dimethylammonio"

Phrase: "]-1-propanesulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.243: CSF, cerebrospinal fluid. 

Phrase: "CSF,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "cerebrospinal fluid."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
Processing 00000000.tx.244: * This work was supported by National Institutes of Health Grants HL51614, NS43284, and NS38195 and by the Yamanouchi USA Foundation. 

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institutes of Health Grants HL51614,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   744   C0018173:Grants [Quantitative Concept]
   744   C0018684:Health [Idea or Concept]
   744   C0021622:Institutes [Organization]
   744   C1521721:Supported [Conceptual Entity]
   744   C3245503:national [Intellectual Product]
   711 E C0183683:Support [Medical Device]
   711 E C1272753:Institute [Idea or Concept]
   711 E C1548284:Grant [Idea or Concept]

Phrase: "NS43284,"

Phrase: "and"

Phrase: "NS38195"

Phrase: "and by the Yamanouchi USA Foundation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0016617:Foundation [Organization]
   753   C0041703:USA [Geographic Area]
   753   C1515981:And [Idea or Concept]
Processing 00000000.tx.245: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.246: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.247: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.248: To whom correspondence should be addressed: Cerebrovascular Research, Cleveland Clinic Foundation NB20, Neurosurgery, 9500 Euclid Ave./NB20, Cleveland, OH 44195. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Cerebrovascular Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "Cleveland Clinic Foundation NB20,"

Phrase: "Neurosurgery,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027926:Neurosurgery [Biomedical Occupation or Discipline]
  1000   C0524850:Neurosurgery [Therapeutic or Preventive Procedure]

Phrase: "9500 Euclid Ave./NB20,"

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "OH 44195."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]
Processing 00000000.tx.249: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.250: 216-445-0561; 

Phrase: "216-445-0561"

Phrase: ";"
Processing 00000000.tx.251: Fax: 216-444-1466; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "216-444-1466"

Phrase: ";"
Processing 00000000.tx.252: E-mail: janigrd{at}ccf.org  REFERENCES TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Rosenberg, G. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "janigrd{at}ccf."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0009081:CCF [Congenital Abnormality]
   827   C0018802:ccf [Disease or Syndrome]

Phrase: "org"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522486:ORG [Professional or Occupational Group]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979969:Rosenberg [Spatial Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.253: A., Kornfeld, M., Estrada, E., Kelley, R. 

Phrase: "A.,"

Phrase: "Kornfeld,"

Phrase: "M."

Phrase: ","

Phrase: "Estrada,"

Phrase: "E.,"

Phrase: "Kelley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.254: O., Liotta, L. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Liotta,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.255: A., and Stetler-Stevenson, W. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Stetler-Stevenson,"

Phrase: "W."
Processing 00000000.tx.256: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.257: (1992) TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. 

Phrase: "(1992"

Phrase: ")"

Phrase: "TIMP-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145946:TIMP-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3178655:TIMP-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "reduces"

Phrase: "proteolytic opening of blood-brain barrier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0175566:Opening [Spatial Concept]
   753   C1882151:Opening [Spatial Concept]

Phrase: "by type IV collagenase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0172537:Type IV collagenase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0441732:Type IV [Classification]
   827   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.258: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.259: 576, 203 207[CrossRef][Medline] Okada, Y., Copeland, B. 

Phrase: "576,"

Phrase: "203 207"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Okada,"

Phrase: "Y.,"

Phrase: "Copeland,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.260: R., Fitridge, R., Koziol, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fitridge,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Koziol,"

Phrase: "J."
Processing 00000000.tx.261: A., and del Zoppo, G. 

Phrase: "A.,"

Phrase: "and"

Phrase: "del Zoppo,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.262: J. 

Phrase: "J."
Processing 00000000.tx.263: (1994) Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "contributes to microvascular obstructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0028778:OBSTRUCTIONS [Pathologic Function]
   770   C0443258:Microvascular [Functional Concept]
   770   C1880177:Contribute [Activity]
   737 E C1882136:OBSTRUCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "parenchymal changes during early focal cerebral ischemia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   721   C2826576:Ischemic Change [Finding]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "reperfusion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035124:Reperfusion [Therapeutic or Preventive Procedure]
  1000   C0684253:reperfusion [Biologic Function]
Processing 00000000.tx.264: Stroke 25, 1847 1853[Abstract] Mun-Bryce, S., and Rosenberg, G. 

Phrase: "Stroke 25,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038454:Stroke [Disease or Syndrome]

Phrase: "1847 1853"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450336:1853 [Intellectual Product]

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mun-Bryce,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979969:Rosenberg [Spatial Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.265: A. 

Phrase: "A."
Processing 00000000.tx.266: (1998) Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Gelatinase B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0165519:Gelatinase B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:GELATINASE B [Gene or Genome]
  1000   C2698028:Gelatinase B [Laboratory Procedure]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "selective opening of the blood-brain barrier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0175566:Opening [Spatial Concept]
   748   C1882151:Opening [Spatial Concept]

Phrase: "during inflammation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]
Processing 00000000.tx.267: Am. 

Phrase: "Am."
Processing 00000000.tx.268: J. 

Phrase: "J."
Processing 00000000.tx.269: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.270: 274, R1203 R1211[Medline] del Zoppo, G. 

Phrase: "274,"

Phrase: "R1203 R1211"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] del Zoppo,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.271: J., and Hallenbeck, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Hallenbeck,"

Phrase: "J."
Processing 00000000.tx.272: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.273: (2000) Advances in the vascular pathophysiology of ischemic stroke. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Advances in the vascular pathophysiology of ischemic stroke."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0948008:Ischaemic stroke [Disease or Syndrome]
   770   C3272363:Ischemic Stroke [Disease or Syndrome]
   744   C0005847:vascular [Body Part, Organ, or Organ Component]
   744   C0031847:pathophysiology [Functional Concept]
   744   C0038454:Stroke [Disease or Syndrome]
   744   C0277785:Pathophysiology [Qualitative Concept]
   744   C0475224:Ischaemic [Functional Concept]
   744   C0725066:Advance [Medical Device]
   744   C1558950:VASCULAR [Finding]
   744   C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.274: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.275: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.276: 98, 73 81[CrossRef] Haas, T. 

Phrase: "98,"

Phrase: "73 81"

Phrase: "[CrossRef"

Phrase: "] Haas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1828470:HAA [Cell Component]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.277: L., and Madri, J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Madri,"

Phrase: "J."
Processing 00000000.tx.278: A. 

Phrase: "A."
Processing 00000000.tx.279: (1999) Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: implications for angiogenesis. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Extracellular matrix-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015350:Extracellular Matrix [Tissue]
   861   C0521119:Extracellular [Cell Component]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "matrix metalloproteinase production in endothelial cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: ":"

Phrase: "implications for angiogenesis."
Processing 00000000.tx.280: Trends Cardiovasc. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cardiovasc."
Processing 00000000.tx.281: Med. 

Phrase: "Med."
Processing 00000000.tx.282: 9, 70 77[CrossRef][Medline] Sternlicht, M. 

Phrase: "9,"

Phrase: "70 77"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sternlicht,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.283: D., and Werb, Z. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Werb,"

Phrase: "Z."
Processing 00000000.tx.284: (2001) How matrix metalloproteinases regulate cell behavior. 

Phrase: "(2001"

Phrase: ")"

Phrase: "How matrix metalloproteinases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "regulate"

Phrase: "cell behavior."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]
Processing 00000000.tx.285: Annu. 

Phrase: "Annu."
Processing 00000000.tx.286: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.287: Cell Dev. 

Phrase: "Cell Dev."
Processing 00000000.tx.288: Biol. 

Phrase: "Biol."
Processing 00000000.tx.289: 17, 463 516[CrossRef][Medline] Nguyen, M., Arkell, J., and Jackson, C. 

Phrase: "17,"

Phrase: "463 516"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nguyen,"

Phrase: "M."

Phrase: ","

Phrase: "Arkell,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Jackson,"

Phrase: "C."
Processing 00000000.tx.290: J. 

Phrase: "J."
Processing 00000000.tx.291: (2001) Human endothelial gelatinases and angiogenesis. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Human endothelial gelatinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206528:Gelatinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.292: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.293: J. 

Phrase: "J."
Processing 00000000.tx.294: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.295: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.296: 33, 960 970[CrossRef][Medline] Lukes, A., Mun-Bryce, S., Lukes, M., and Rosenberg, G. 

Phrase: "33,"

Phrase: "960 970"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lukes,"

Phrase: "A.,"

Phrase: "Mun-Bryce,"

Phrase: "S."

Phrase: ","

Phrase: "Lukes,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979969:Rosenberg [Spatial Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.297: A. 

Phrase: "A."
Processing 00000000.tx.298: (1999) Extracellular matrix degradation by metalloproteinases and central nervous system diseases. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Extracellular matrix degradation by metalloproteinases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C1517052:Extracellular Matrix Degradation [Cell Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "central nervous system diseases."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0007682:Central Nervous System Diseases [Disease or Syndrome]
   923   C0027765:Nervous System Diseases [Disease or Syndrome]
           Nerve Diseases
   812   C0012634:Diseases [Disease or Syndrome]
   808   C0442893:Systemic disease [Disease or Syndrome]
   756   C0927232:Central Nervous System [Body System]
   756   C1269563:Central nervous system [Body System]
   741 E C1836721:MALS [Finding]
   741 E C3538764:MALS [Gene or Genome]
   741 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.299: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.300: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.301: 19, 267 284[Medline] Mun-Bryce, S., and Rosenberg, G. 

Phrase: "19,"

Phrase: "267 284"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mun-Bryce,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979969:Rosenberg [Spatial Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.302: A. 

Phrase: "A."
Processing 00000000.tx.303: (1998) Matrix metalloproteinases in cerebrovascular disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Matrix metalloproteinases in cerebrovascular disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
Processing 00000000.tx.304: J. 

Phrase: "J."
Processing 00000000.tx.305: Cereb. 

Phrase: "Cereb."
Processing 00000000.tx.306: Blood Flow Metab. 

Phrase: "Blood Flow Metab."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0232338:Blood flow [Organism Function]
Processing 00000000.tx.307: 18, 1163 1172[Medline] Lo, E. 

Phrase: "18,"

Phrase: "1163 1172"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lo,"

Phrase: "E."
Processing 00000000.tx.308: H., Wang, X., and Cuzner, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "X.,"

Phrase: "and"

Phrase: "Cuzner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.309: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.310: (2002) Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Extracellular proteolysis in brain injury"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597304:Proteolysis [Molecular Function]

Phrase: "and"

Phrase: "inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: ":"

Phrase: "role for plasminogen activators"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "matrix metalloproteinases."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]
Processing 00000000.tx.311: J. 

Phrase: "J."
Processing 00000000.tx.312: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.313: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.314: 69, 1 9[CrossRef][Medline] Rosenberg, G. 

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "1 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979969:Rosenberg [Spatial Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.315: A., Estrada, E. 

Phrase: "A.,"

Phrase: "Estrada,"

Phrase: "E."
Processing 00000000.tx.316: Y., and Dencoff, J. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Dencoff,"

Phrase: "J."
Processing 00000000.tx.317: E. 

Phrase: "E."
Processing 00000000.tx.318: (1998) Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Matrix metalloproteinases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "TIMPs"

Phrase: "are"

Phrase: "associated with blood-brain barrier opening"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   833   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
   833   C1305865:Blood-brain barrier [Organ or Tissue Function]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0175566:Opening [Spatial Concept]
   753   C0229664:Blood [Body Substance]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1706912:BARRIER [Medical Device]
   753   C1882151:Opening [Spatial Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "after reperfusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035124:Reperfusion [Therapeutic or Preventive Procedure]
  1000   C0684253:reperfusion [Biologic Function]

Phrase: "in rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.319: Stroke 29, 2189 2195[Abstract/Free FullText] Stanimirovic, D., and Satoh, K. 

Phrase: "Stroke 29,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038454:Stroke [Disease or Syndrome]

Phrase: "2189 2195"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stanimirovic,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Satoh,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.320: (2000) Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Inflammatory mediators of cerebral endothelium"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   760   C0333348:Inflammatory [Functional Concept]
   726 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "a role in ischemic brain inflammation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.321: Brain Pathol. 

Phrase: "Brain Pathol."
Processing 00000000.tx.322: 10, 113 126[Medline] Woessner, J. 

Phrase: "10,"

Phrase: "113 126"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Woessner,"

Phrase: "J."
Processing 00000000.tx.323: F., Jr. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.324: (1999) Matrix metalloproteinase inhibition. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Matrix metalloproteinase inhibition."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]
   734   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.325: From the Jurassic to the third millennium. 

Phrase: "From the Jurassic"

Phrase: "to the third millennium."
Processing 00000000.tx.326: Ann. 

Phrase: "Ann."
Processing 00000000.tx.327: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.328: Y. 

Phrase: "Y."
Processing 00000000.tx.329: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.330: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.331: 878, 388 403[Abstract/Free FullText] Beekman, B., Drijfhout, J. 

Phrase: "878,"

Phrase: "388 403"

Phrase: "[Abstract/Free FullText"

Phrase: "] Beekman,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Drijfhout,"

Phrase: "J."
Processing 00000000.tx.332: W., Ronday, H. 

Phrase: "W., Ronday,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.333: K., and TeKoppele, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "TeKoppele,"

Phrase: "J."
Processing 00000000.tx.334: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.335: (1999) Fluorogenic MMP activity assay for plasma including MMPs complexed to 2-macroglobulin Ann. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Fluorogenic MMP activity assay for plasma"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0205177:Activity [Functional Concept]
   753   C0243073:assay [Qualitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "MMPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0623362:MMPs [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C0919336:MMP [Gene or Genome]

Phrase: "complexed to 2-macroglobulin Ann."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   726   C0439855:Complex [Qualitative Concept]
   726   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.336: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.337: Y. 

Phrase: "Y."
Processing 00000000.tx.338: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.339: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.340: 878, 150 158[Abstract/Free FullText] Aschner, M. 

Phrase: "878,"

Phrase: "150 158"

Phrase: "[Abstract/Free FullText"

Phrase: "] Aschner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.341: (1998) Immune and inflammatory responses in the CNS: modulation by astrocytes. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Immune"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439662:Immune [Functional Concept]

Phrase: "and"

Phrase: "inflammatory responses in the CNS"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   806   C1155266:inflammatory responses [Pathologic Function]
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: ":"

Phrase: "modulation by astrocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0443264:Modulation [Spatial Concept]
Processing 00000000.tx.342: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.343: Lett. 

Phrase: "Lett."
Processing 00000000.tx.344: 102103, 283 287[CrossRef] Bode, J. 

Phrase: "102103,"

Phrase: "283 287"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "Bode"

Phrase: ","

Phrase: "J."
Processing 00000000.tx.345: G., Fischer, R., Haussinger, D., Graeve, L., Heinrich, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Fischer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Haussinger,"

Phrase: "D."

Phrase: ","

Phrase: "Graeve,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Heinrich,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.346: C., and Schaper, F. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Schaper,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.347: (2001) The inhibitory effect of IL-1 on IL-6-induced 2-macroglobulin expression is due to activation of NF-B. 

Phrase: "(2001"

Phrase: ")"

Phrase: "The inhibitory effect of IL-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on IL-6-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0021760:IL6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334122:IL6 [Gene or Genome]
  1000   C2983957:IL-6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "2-macroglobulin expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is due to activation of NF-B."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0678226:Due to [Functional Concept]
           due
   748   C1879547:Activation [Activity]
   748   C3146286:Due [Idea or Concept]
Processing 00000000.tx.348: J. 

Phrase: "J."
Processing 00000000.tx.349: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.350: 167, 1469 1481[Abstract/Free FullText] Gao, F., Bales, K. 

Phrase: "167,"

Phrase: "1469 1481"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gao,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.351: R., Dodel, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dodel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.352: C., Liu, J., Chen, X., Hample, H., Farlow, M. 

Phrase: "C., Liu,"

Phrase: "J.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "X.,"

Phrase: "Hample,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Farlow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.353: R., Paul, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.354: M., and Du, Y. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540681:DU [Idea or Concept]

Phrase: "Y."
Processing 00000000.tx.355: (2002) NF-B mediates IL-1-induced synthesis/release of (2)-macroglobulin in a human glial cell line. 

Phrase: "(2002"

Phrase: ")"

Phrase: "NF-B"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "IL-1-induced synthesis/release of (2"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   893   C0021756:il 2 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0020898:IL [Geographic Area]
   795   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0022271:IL [Geographic Area]
   795   C0030685:Release [Health Care Activity]
   795   C0205263:Induced [Functional Concept]
   795   C0220781:synthesis [Biologic Function]
   795   C0391871:Release [Functional Concept]
   795   C0439180:% release [Quantitative Concept]
   795   C0680255:release [Health Care Activity]
   795   C1283071:Release [Functional Concept]
   795   C1883254:Synthesis [Activity]
   795   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: ")-"

Phrase: "macroglobulin in a human glial cell line."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.356: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.357: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.358: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.359: 105, 108 114[Medline] Marzolo, M. 

Phrase: "105,"

Phrase: "108 114"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Marzolo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.360: P., von Bernhardi, R., Bu, G., and Inestrosa, N. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "von Bernhardi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006463:BU [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Inestrosa,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.361: C. 

Phrase: "C."
Processing 00000000.tx.362: (2000) Expression of (2)-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Expression of (2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ")-"

Phrase: "macroglobulin receptor/low density lipoprotein receptor-related protein (LRP)"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   878   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   864   C0242972:low protein [Therapeutic or Preventive Procedure]
   864   C0748025:low protein [Finding]
   861   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   835   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   822   C0599283:receptor density [Genetic Function]
   793   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0178587:density [Quantitative Concept]
   793   C0205251:low [Qualitative Concept]
   793   C0439849:Related [Qualitative Concept]
   793   C0445223:Related [Finding]
   793   C1299352:Low [Qualitative Concept]
   793   C1550472:low [Idea or Concept]
   760 E C0163712:Relate [Organic Chemical]
   721 E C0080103:Relation [Family Group]
   721 E C0439794:Dense [Qualitative Concept]
   721 E C0869014:Relations [Social Behavior]

Phrase: "in rat microglial cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0206116:Microglial cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.363: J. 

Phrase: "J."
Processing 00000000.tx.364: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.365: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.366: 60, 401 411[CrossRef][Medline] Harkness, K. 

Phrase: "60,"

Phrase: "401 411"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Harkness,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.367: A., Adamson, P., Sussman, J. 

Phrase: "A.,"

Phrase: "Adamson,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sussman,"

Phrase: "J."
Processing 00000000.tx.368: D., Davies-Jones, G. 

Phrase: "D."

Phrase: ","

Phrase: "Davies-Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.369: A., Greenwood, J., and Woodroofe, M. 

Phrase: "A.,"

Phrase: "Greenwood,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Woodroofe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.370: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.371: (2000) Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Dexamethasone regulation of matrix metalloproteinase expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "in CNS vascular endothelium."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0014261:Endothelium, Vascular [Tissue]
   873 E C1706972:Blood Vessel Endothelium [Tissue]
   827   C0014257:Endothelium [Tissue]
Processing 00000000.tx.372: Brain 123, 698 709[Abstract/Free FullText] Hedley-Whyte, E. 

Phrase: "Brain 123,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "698 709"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hedley-Whyte,"

Phrase: "E."
Processing 00000000.tx.373: T., and Hsu, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hsu,"

Phrase: "D."
Processing 00000000.tx.374: W. 

Phrase: "W."
Processing 00000000.tx.375: (1986) Effect of dexamethasone on blood-brain barrier in the normal mouse. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Effect of dexamethasone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "in the normal mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]
Processing 00000000.tx.376: Ann. 

Phrase: "Ann."
Processing 00000000.tx.377: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.378: 19, 373 377[Medline] Bowen, M. 

Phrase: "19,"

Phrase: "373 377"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bowen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.379: E., and Gettins, P. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Gettins,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.380: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.381: (1998) Bait region involvement in the dimer-dimer interface of human 2-macroglobulin and in mediating gross conformational change. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Bait region involvement in the dimer-dimer interface of human 2-macroglobulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1314939:Involvement [Functional Concept]

Phrase: "and in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "gross conformational change."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0301641:Conformational change [Molecular Function]
   827   C0392747:Change [Functional Concept]
   827   C0443172:change [Quantitative Concept]
   827   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.382: Evidence from cysteine variants that form interdimer disulfides. 

Phrase: "Evidence from cysteine variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "interdimer disulfides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012771:Disulfides [Chemical Viewed Structurally]
Processing 00000000.tx.383: J. 

Phrase: "J."
Processing 00000000.tx.384: Biol. 

Phrase: "Biol."
Processing 00000000.tx.385: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.386: 273, 1825 1831[Abstract/Free FullText] Gettins, P. 

Phrase: "273,"

Phrase: "1825 1831"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gettins,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.387: G., Hahn, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hahn,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.388: H., and Crews, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Crews,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.389: C. 

Phrase: "C."
Processing 00000000.tx.390: (1995) 2-Macroglobulin bait region variants. 

Phrase: "(1995"

Phrase: ")"

Phrase: "2-Macroglobulin bait region variants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205419:variants [Qualitative Concept]
Processing 00000000.tx.391: A role for the bait region in tetramer formation. 

Phrase: "A role for the bait region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in tetramer formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.392: J. 

Phrase: "J."
Processing 00000000.tx.393: Biol. 

Phrase: "Biol."
Processing 00000000.tx.394: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.395: 270, 14160 14167[Abstract/Free FullText] Dennis, P. 

Phrase: "270,"

Phrase: "14160 14167"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dennis,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.396: A., Saksela, O., Harpel, P., and Rifkin, D. 

Phrase: "A.,"

Phrase: "Saksela,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Harpel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Rifkin,"

Phrase: "D."
Processing 00000000.tx.397: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.398: (1989) 2-Macroglobulin is a binding protein for basic fibroblast growth factor. 

Phrase: "(1989"

Phrase: ")"

Phrase: "2-Macroglobulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "a binding protein for basic fibroblast growth factor."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   822   C1149300:fibroblast growth factor binding [Molecular Function]
   793   C1149299:Growth Factor Binding [Molecular Function]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C0033618:Protein Binding [Molecular Function]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
Processing 00000000.tx.399: J. 

Phrase: "J."
Processing 00000000.tx.400: Biol. 

Phrase: "Biol."
Processing 00000000.tx.401: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.402: 264, 7210 7216[Abstract/Free FullText] Ronne, H., Anundi, H., Rask, L., and Peterson, P. 

Phrase: "264,"

Phrase: "7210 7216"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ronne,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Anundi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rask,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Peterson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.403: A. 

Phrase: "A."
Processing 00000000.tx.404: (1979) Nerve growth factor binds to serum 2-macroglobulin. 

Phrase: "(1979"

Phrase: ")"

Phrase: "Nerve growth factor"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C0814002:Neural Growth [Cell Function,Organism Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0220844:growth [Physiologic Function]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: "binds to serum 2-macroglobulin."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0229671:Serum [Body Substance]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
Processing 00000000.tx.405: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.406: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.407: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.408: Commun. 

Phrase: "Commun."
Processing 00000000.tx.409: 87, 330 336[Medline] Desai, S., Marroni, M., Cucullo, L., Bengez, L., Hossein, M., Mayberg, M. 

Phrase: "87,"

Phrase: "330 336"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Desai,"

Phrase: "S."

Phrase: ","

Phrase: "Marroni,"

Phrase: "M."

Phrase: ","

Phrase: "Cucullo,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bengez,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hossein,"

Phrase: "M."

Phrase: ","

Phrase: "Mayberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.410: R., Grant, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Grant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.411: A., and Janigro, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Janigro,"

Phrase: "D."
Processing 00000000.tx.412: (2002) Mechanisms of endothelial survival under shear stress. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Mechanisms of endothelial survival"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "under shear stress."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1171318:shear stress [Natural Phenomenon or Process]
   861   C0038435:Stress [Finding]
   861   C0175735:shear [Medical Device]
   861   C0205013:shear [Therapeutic or Preventive Procedure]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.413: Endothelium 9, 89 102[Medline] Dombrowski, S., Desai, S., Marroni, M., Cucullo, L., Bingaman, W., Mayberg, M. 

Phrase: "Endothelium 9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014257:Endothelium [Tissue]

Phrase: "89 102"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dombrowski,"

Phrase: "S."

Phrase: ","

Phrase: "Desai,"

Phrase: "S."

Phrase: ","

Phrase: "Marroni,"

Phrase: "M."

Phrase: ","

Phrase: "Cucullo,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bingaman,"

Phrase: "W.,"

Phrase: "Mayberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.414: R., Bengez, L., and Janigro, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bengez,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Janigro,"

Phrase: "D."
Processing 00000000.tx.415: (2001) Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Overexpression of multiple drug resistance genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "in endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with refractory epilepsy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1096063:Refractory epilepsy [Disease or Syndrome]
   861   C0014544:Epilepsy [Disease or Syndrome]
Processing 00000000.tx.416: Epilepsia 42, 1504 1507 Neuwelt, E. 

Phrase: "Epilepsia 42,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014544:epilepsia [Disease or Syndrome]

Phrase: "1504 1507 Neuwelt,"

Phrase: "E."
Processing 00000000.tx.417: A., Goldman, D. 

Phrase: "A.,"

Phrase: "Goldman,"

Phrase: "D."
Processing 00000000.tx.418: L., Dahlborg, S. 

Phrase: "L., Dahlborg,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.419: A., Crossen, J., Ramsey, F., Roman Goldstein, S., Braziel, R., and Dana, B. 

Phrase: "A.,"

Phrase: "Crossen,"

Phrase: "J.,"

Phrase: "Ramsey,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Roman Goldstein,"

Phrase: "S."

Phrase: ","

Phrase: "Braziel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Dana,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.420: (1991) Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Primary CNS lymphoma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0280803:Primary CNS lymphoma [Neoplastic Process]
   901   C0742472:CNS Lymphoma [Neoplastic Process]
   827   C0024299:Lymphoma [Neoplastic Process]

Phrase: "treated with osmotic blood-brain barrier disruption"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   853   C1511220:blood-brain barrier disruption [Therapeutic or Preventive Procedure]
   853   C1831732:Blood-Brain Barrier Disruption [Therapeutic or Preventive Procedure]
   814   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
   814   C1305865:Blood-brain barrier [Organ or Tissue Function]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0029391:osmotic [Natural Phenomenon or Process]
   748   C0229664:Blood [Body Substance]
   748   C0311417:Osmotic [Functional Concept]
   748   C0332453:Disruption [Functional Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1522326:Treated [Functional Concept]
   748   C1706912:BARRIER [Medical Device]
   714 E C1292734:TREAT [Functional Concept]

Phrase: ":"

Phrase: "prolonged survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "and"

Phrase: "preservation of cognitive function."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033085:Preservation [Laboratory Procedure]
   770   C1514402:Preservation [Laboratory Procedure]
Processing 00000000.tx.421: J. 

Phrase: "J."
Processing 00000000.tx.422: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.423: Oncol. 

Phrase: "Oncol."
Processing 00000000.tx.424: 9, 1580 1590[Abstract] Kroll, R. 

Phrase: "9,"

Phrase: "1580 1590"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kroll,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.425: A., and Neuwelt, E. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Neuwelt,"

Phrase: "E."
Processing 00000000.tx.426: A. 

Phrase: "A."
Processing 00000000.tx.427: (1998) Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Outwitting"

Phrase: "the blood-brain barrier for therapeutic purposes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
   814   C1305865:Blood-brain barrier [Organ or Tissue Function]
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0229664:Blood [Body Substance]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1706912:BARRIER [Medical Device]

Phrase: ":"

Phrase: "osmotic opening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0175566:Opening [Spatial Concept]
   861   C1882151:Opening [Spatial Concept]

Phrase: "and"

Phrase: "other means."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.428: Neurosurgery 42, 1083 1099[Medline] Roman-Goldstein, S., Mitchell, P., Crossen, J. 

Phrase: "Neurosurgery 42,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027926:Neurosurgery [Biomedical Occupation or Discipline]
   861   C0524850:Neurosurgery [Therapeutic or Preventive Procedure]

Phrase: "1083 1099"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Roman-Goldstein,"

Phrase: "S."

Phrase: ","

Phrase: "Mitchell,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Crossen,"

Phrase: "J."
Processing 00000000.tx.429: R., Williams, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Williams,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.430: C., Tindall, A., and Neuwelt, E. 

Phrase: "C., Tindall,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Neuwelt,"

Phrase: "E."
Processing 00000000.tx.431: A. 

Phrase: "A."
Processing 00000000.tx.432: (1995) MR and cognitive testing of patients undergoing osmotic blood-brain barrier disruption with intraarterial chemotherapy. 

Phrase: "(1995"

Phrase: ")"

Phrase: "MR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347167:Mr. [Conceptual Entity]

Phrase: "and"

Phrase: "cognitive testing of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0039593:Testing [Functional Concept]
   770   C0392366:testing [Intellectual Product]

Phrase: "undergoing"

Phrase: "osmotic blood-brain barrier disruption with intraarterial chemotherapy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   855   C1511220:Blood-Brain Barrier Disruption Chemotherapy [Therapeutic or Preventive Procedure]
           blood-brain barrier disruption
   833   C1831732:Blood-Brain Barrier Disruption [Therapeutic or Preventive Procedure]
   744   C0332453:Disruption [Functional Concept]
Processing 00000000.tx.433: Am. 

Phrase: "Am."
Processing 00000000.tx.434: J. 

Phrase: "J."
Processing 00000000.tx.435: Neuroradiol. 

Phrase: "Neuroradiol."
Processing 00000000.tx.436: 16, 543 553[Abstract] Marchi, N., Fazio, V., Cucullo, L., Kight, K., Masaryk, T. 

Phrase: "16,"

Phrase: "543 553"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Marchi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Fazio,"

Phrase: "V.,"

Phrase: "Cucullo,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kight,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Masaryk,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.437: J., Barnett, G., Vogelbaum, M., Kinter, M., Mayberg, M. 

Phrase: "J.,"

Phrase: "Barnett,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vogelbaum,"

Phrase: "M."

Phrase: ","

Phrase: "Kinter,"

Phrase: "M."

Phrase: ","

Phrase: "Mayberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.438: R., and Janigro, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Janigro,"

Phrase: "D."
Processing 00000000.tx.439: (2002) Serum transthyretin as a possible marker of blood-to-CSF barrier disruption. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Serum transthyretin as a possible marker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032923:Transthyretin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1421224:TRANSTHYRETIN [Gene or Genome]

Phrase: "of blood-to-CSF barrier disruption."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332453:Disruption [Functional Concept]
   734   C0234562:Blood-cerebrospinal fluid barrier [Organ or Tissue Function]
Processing 00000000.tx.440: J. 

Phrase: "J."
Processing 00000000.tx.441: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.442: 23, 1949 1955 Marchi, N., Rasmussen, P. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "1949 1955 Marchi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Rasmussen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.443: A., Kapural, M., Fazio, V., Cavaglia, M., and Janigro, D. 

Phrase: "A.,"

Phrase: "Kapural,"

Phrase: "M."

Phrase: ","

Phrase: "Fazio,"

Phrase: "V.,"

Phrase: "Cavaglia,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Janigro,"

Phrase: "D."
Processing 00000000.tx.444: (2002) Peripheral markers of brain damage and blood-brain barrier dysfunction. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Peripheral markers of brain damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0005516:Marker [Clinical Attribute]

Phrase: "and"

Phrase: "blood-brain barrier dysfunction."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   875   C0262405:brain dysfunction [Disease or Syndrome]
   812   C0031847:dysfunction [Functional Concept]
   812   C0277785:Dysfunction, NOS [Qualitative Concept]
   756   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
   756 E C0231174:Malfunction [Functional Concept]
   756   C1305865:Blood-brain barrier [Organ or Tissue Function]
   756 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.445: Restor. 

Phrase: "Restor."
Processing 00000000.tx.446: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.447: Neurosci., in press Georgiadis, D., Berger, A., Kowatschev, E., Lautenschlager, C., Borner, A., Lindner, A., Schulte-Mattler, W., Zerkowski, H. 

Phrase: "Neurosci.,"

Phrase: "in press Georgiadis,"

Phrase: "D."

Phrase: ","

Phrase: "Berger,"

Phrase: "A.,"

Phrase: "Kowatschev,"

Phrase: "E.,"

Phrase: "Lautenschlager,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Borner,"

Phrase: "A.,"

Phrase: "Lindner,"

Phrase: "A.,"

Phrase: "Schulte-Mattler,"

Phrase: "W.,"

Phrase: "Zerkowski,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.448: R., Zierz, S., and Deufel, T. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Zierz,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Deufel,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.449: (2000) Predictive value of S-100 and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Predictive value of S-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1514307:Predictive Value [Qualitative Concept]
   804   C0681890:predictive [Qualitative Concept]
   804   C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "neuron-specific enolase serum levels for adverse neurologic outcome"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   742   C0229671:Serum [Body Substance]
   742   C0441889:Levels [Qualitative Concept]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "after cardiac surgery."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018821:Cardiac Surgery [Therapeutic or Preventive Procedure]
  1000   C0524727:Surgery, Cardiac [Biomedical Occupation or Discipline]
   861   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   861   C0038894:Surgery [Biomedical Occupation or Discipline]
   861   C0038895:surgery [Functional Concept]
   861   C0543467:Surgery [Health Care Activity]
   861   C1522601:Cardiac [Spatial Concept]
Processing 00000000.tx.450: J. 

Phrase: "J."
Processing 00000000.tx.451: Thorac. 

Phrase: "Thorac."
Processing 00000000.tx.452: Cardiovasc. 

Phrase: "Cardiovasc."
Processing 00000000.tx.453: Surg. 

Phrase: "Surg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541227:Surg [Temporal Concept]
Processing 00000000.tx.454: 119, 138 147[Abstract/Free FullText] Kapural, M., Bengez, L., Barnett, G., Perl, J., II, Masaryk, T. 

Phrase: "119,"

Phrase: "138 147"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kapural,"

Phrase: "M."

Phrase: ","

Phrase: "Bengez,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Barnett,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Perl,"

Phrase: "J.,"

Phrase: "II,"

Phrase: "Masaryk,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.455: J., Apollo, D., Mayberg, M. 

Phrase: "J.,"

Phrase: "Apollo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425019:APOLLO [Gene or Genome]
  1000   C2984598:APOLLO [Gene or Genome]

Phrase: "D."

Phrase: ","

Phrase: "Mayberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.456: R., and Janigro, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Janigro,"

Phrase: "D."
Processing 00000000.tx.457: (2002) S-100 as a possible serum marker for disruption on the blood-brain barrier. 

Phrase: "(2002"

Phrase: ")"

Phrase: "S-100 as a possible serum marker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1441165:S-100 [Immunologic Factor]
   748   C2603362:S' [Clinical Attribute]

Phrase: "for disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332453:Disruption [Functional Concept]

Phrase: "on the blood-brain barrier."
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.458: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.459: 940, 102 104[CrossRef][Medline] Grant, G. 

Phrase: "940,"

Phrase: "102 104"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Grant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.460: A., Abbott, N. 

Phrase: "A.,"

Phrase: "Abbott,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331761:Abbott [Health Care Related Organization]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.461: J., and Janigro, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Janigro,"

Phrase: "D."
Processing 00000000.tx.462: (1998) Understanding the physiology of the blood-brain barrier: in vitro models. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the physiology of the blood-brain barrier"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0005811:Blood Physiology [Organ or Tissue Function]
   748   C0031842:Physiology [Biomedical Occupation or Discipline]
   748   C0031843:physiology [Physiologic Function]
   738   C1704512:Physiologic Barrier [Finding]

Phrase: ":"

Phrase: "in vitro models."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C1515654:In Vitro Model [Research Activity]
   827   C3161035:Models [Intellectual Product]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.463: News Physiol. 

Phrase: "News Physiol."
Processing 00000000.tx.464: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.465: 13, 287 293[Abstract/Free FullText] Revest, P. 

Phrase: "13,"

Phrase: "287 293"

Phrase: "[Abstract/Free FullText"

Phrase: "] Revest,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.466: A., Jones, H. 

Phrase: "A.,"

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.467: C., and Abbott, N. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Abbott,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331761:Abbott [Health Care Related Organization]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.468: J. 

Phrase: "J."
Processing 00000000.tx.469: (1993) The transendothelial DC potential of rat blood-brain barrier vessels in situ. 

Phrase: "(1993"

Phrase: ")"

Phrase: "The transendothelial DC potential of rat blood-brain barrier vessels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C3245505:Potential [Qualitative Concept]

Phrase: "in situ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444498:In situ [Spatial Concept]
Processing 00000000.tx.470: Cereb. 

Phrase: "Cereb."
Processing 00000000.tx.471: Vasc. 

Phrase: "Vasc."
Processing 00000000.tx.472: Biol. 

Phrase: "Biol."
Processing 00000000.tx.473: 331, 71 74 Abbott, N. 

Phrase: "331,"

Phrase: "71 74 Abbott,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331761:Abbott [Health Care Related Organization]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.474: J., Revest, P. 

Phrase: "J.,"

Phrase: "Revest,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.475: A., and Romero, I. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Romero,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.476: A. 

Phrase: "A."
Processing 00000000.tx.477: (1992) Astrocyte-endothelial interaction: physiology and pathology. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Astrocyte-endothelial interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: ":"

Phrase: "physiology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "and"

Phrase: "pathology."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.478: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.479: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.480: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.481: 18, 424 433[Medline] McAllister, M. 

Phrase: "18,"

Phrase: "424 433"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McAllister,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.482: S., Krizanac-Bengez, L., Macchia, F., Naftalin, R. 

Phrase: "S."

Phrase: ","

Phrase: "Krizanac-Bengez,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Macchia,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Naftalin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.483: J., Pedley, K. 

Phrase: "J.,"

Phrase: "Pedley,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.484: C., Mayberg, M. 

Phrase: "C., Mayberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.485: R., Marroni, M., Leaman, S., Stanness, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Marroni,"

Phrase: "M."

Phrase: ","

Phrase: "Leaman,"

Phrase: "S."

Phrase: ","

Phrase: "Stanness,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.486: A., and Janigro, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Janigro,"

Phrase: "D."
Processing 00000000.tx.487: (2001) Mechanisms of glucose transport at the blood-brain barrier: an in vitro study. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Mechanisms of glucose transport"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "at the blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "an in vitro study."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0681828:in vitro study [Research Activity]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.488: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.489: 904, 20 30[CrossRef][Medline] Kondo, T., Sakaguchi, M., and Namba, M. 

Phrase: "904,"

Phrase: "20 30"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kondo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sakaguchi,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Namba,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.490: (2001) Two-dimensional gel electrophoretic studies on the cellular aging: accumulation of 2-macroglobulin in human fibroblasts with aging. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Two-dimensional gel electrophoretic studies on the cellular aging"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C0947630:studies [Laboratory Procedure]
   708 E C0557651:Study [Manufactured Object]
   708 E C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "accumulation of 2-macroglobulin"

Phrase: "in human fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "with aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]
Processing 00000000.tx.491: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.492: Gerontol. 

Phrase: "Gerontol."
Processing 00000000.tx.493: 36, 487 495[CrossRef][Medline] Rosenberg, G. 

Phrase: "36,"

Phrase: "487 495"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979969:Rosenberg [Spatial Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.494: A. 

Phrase: "A."
Processing 00000000.tx.495: (2002) Matrix metalloproteinases in neuroinflammation. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Matrix metalloproteinases in neuroinflammation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1704640:Matrix [Spatial Concept]
   770   C1706515:Matrix [Body Substance]
Processing 00000000.tx.496: Glia 39, 279 291[CrossRef][Medline] Silvestre, J. 

Phrase: "Glia 39,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027836:Glia [Cell]
   861   C1087003:Glia [Plant]

Phrase: "279 291"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Silvestre,"

Phrase: "J."
Processing 00000000.tx.497: S., Mallat, Z., Tamarat, R., Duriez, M., Tedgui, A., and Levy, B. 

Phrase: "S."

Phrase: ","

Phrase: "Mallat,"

Phrase: "Z.,"

Phrase: "Tamarat,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Duriez,"

Phrase: "M."

Phrase: ","

Phrase: "Tedgui,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Levy,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.498: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.499: (2001) Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Regulation of matrix metalloproteinase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in ischemic tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "by interleukin-10"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0085295:Interleukin-10 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334098:INTERLEUKIN 10 [Gene or Genome]
  1000   C1522550:Interleukin-10 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2983956:INTERLEUKIN-10 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "role in ischemia-induced angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.500: Circ. 

Phrase: "Circ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332520:Circ [Quantitative Concept]
  1000   C2347774:circ [Quantitative Concept]
Processing 00000000.tx.501: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.502: 89, 259 264[Abstract/Free FullText] Tran, N. 

Phrase: "89,"

Phrase: "259 264"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tran,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.503: D., Schreiber, S. 

Phrase: "D."

Phrase: ","

Phrase: "Schreiber,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.504: S., and Fisher, M. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.505: (1998) Astrocyte regulation of endothelial tissue plasminogen activator in a blood-brain barrier model. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Astrocyte regulation of endothelial tissue plasminogen activator"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "in a blood-brain barrier model."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0678910:brain model [Organ or Tissue Function]
   812   C3161035:Model [Intellectual Product]
   756   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
   756   C1305865:Blood-brain barrier [Organ or Tissue Function]
Processing 00000000.tx.506: J. 

Phrase: "J."
Processing 00000000.tx.507: Cereb. 

Phrase: "Cereb."
Processing 00000000.tx.508: Blood Flow Metab. 

Phrase: "Blood Flow Metab."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0232338:Blood flow [Organism Function]
Processing 00000000.tx.509: 18, 1316 1324[Medline] Tran, N. 

Phrase: "18,"

Phrase: "1316 1324"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tran,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.510: D., Correale, J., Schreiber, S. 

Phrase: "D."

Phrase: ","

Phrase: "Correale,"

Phrase: "J.,"

Phrase: "Schreiber,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.511: S., and Fisher, M. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.512: (1999) Transforming growth factor- mediates astrocyte-specific regulation of brain endothelial anticoagulant factors. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Transforming growth factor-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "astrocyte-specific regulation of brain endothelial anticoagulant factors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.513: Stroke 30, 1671 1678[Abstract/Free FullText] Wagner, K. 

Phrase: "Stroke 30,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038454:Stroke [Disease or Syndrome]

Phrase: "1671 1678"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wagner,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.514: R., Xi, G., Ya, H., Zuccarello, M., De Courten-Myers, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Xi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720296:Xi [Intellectual Product]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ya,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Zuccarello,"

Phrase: "M."

Phrase: ","

Phrase: "De Courten-Myers,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.515: M., Broderick, J. 

Phrase: "M."

Phrase: ","

Phrase: "Broderick,"

Phrase: "J."
Processing 00000000.tx.516: P., and Brott, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Brott,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.517: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.518: (1999) Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Ultra-early"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0728475:ultra [Medical Device]
   861   C1279919:Early [Temporal Concept]

Phrase: "clot"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009074:CLOT [Organic Chemical,Pharmacologic Substance]
  1000   C0302148:Clot [Acquired Abnormality]

Phrase: "aspiration after lysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0220787:Aspiration [Health Care Activity]
   790   C0349707:Aspiration [Therapeutic or Preventive Procedure]
   790   C0700198:Aspiration [Pathologic Function]
   790   C2827071:Aspiration [Finding]

Phrase: "with tissue plasminogen activator"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "in a porcine model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "of intracerebral hemorrhage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2937358:Intracerebral Hemorrhage [Pathologic Function]
   861   C0019080:Haemorrhage [Pathologic Function]
   861   C0442111:Intracerebral [Spatial Concept]

Phrase: ":"

Phrase: "edema reduction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0474212:edema reduction [Therapeutic or Preventive Procedure]
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "blood-brain barrier protection."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1545588:Protection [Finding]
   756   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
   756   C1305865:Blood-brain barrier [Organ or Tissue Function]
Processing 00000000.tx.519: J. 

Phrase: "J."
Processing 00000000.tx.520: Neurosurg. 

Phrase: "Neurosurg."
Processing 00000000.tx.521: 90, 491 498[Medline] Kanoh, Y., and Ohtani, H. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "491 498"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kanoh,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Ohtani,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.522: (1997) Levels of interleukin-6, CRP and 2 macroglobulin in cerebrospinal fluid (CSF) and serum as indicator of blood-CSF barrier damage. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Levels of interleukin-6,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "CRP"

Phrase: "and"

Phrase: "2 macroglobulin in cerebrospinal fluid (CSF)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "serum as indicator of blood-CSF barrier damage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0229671:Blood Serum [Body Substance]
           Serum
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
Processing 00000000.tx.523: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.524: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.525: Biol. 

Phrase: "Biol."
Processing 00000000.tx.526: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.527: 43, 269 278[Medline] Schliep, G., Rapic, N., and Felgenhauer, K. 

Phrase: "43,"

Phrase: "269 278"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schliep,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Rapic,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Felgenhauer,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.528: (1974) Quantitation of high-molecular proteins in cerebrospinal fluid. 

Phrase: "(1974"

Phrase: ")"

Phrase: "Quantitation of high-molecular proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantitation [Quantitative Concept]

Phrase: "in cerebrospinal fluid."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
Processing 00000000.tx.529: Z. 

Phrase: "Z."
Processing 00000000.tx.530: Klin. 

Phrase: "Klin."
Processing 00000000.tx.531: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.532: Klin. 

Phrase: "Klin."
Processing 00000000.tx.533: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.534: 12, 367 369[Medline] Felgenhauer, K. 

Phrase: "12,"

Phrase: "367 369"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Felgenhauer,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.535: (1974) Protein size and cerebrospinal fluid composition. 

Phrase: "(1974"

Phrase: ")"

Phrase: "Protein size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "cerebrospinal fluid composition."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0486616:Composition [Clinical Attribute]
   827   C1555710:composition [Idea or Concept]
   734   C0007806:Cerebrospinal Fluid [Body Substance]
   734   C0007807:cerebrospinal fluid [Functional Concept]
Processing 00000000.tx.536: Klin. 

Phrase: "Klin."
Processing 00000000.tx.537: Wochenschr. 

Phrase: "Wochenschr."
Processing 00000000.tx.538: 52, 1158 1164[Medline] Felgenhauer, K., and Hagedorn, D. 

Phrase: "52,"

Phrase: "1158 1164"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Felgenhauer,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hagedorn,"

Phrase: "D."
Processing 00000000.tx.539: (1980) Two-dimensional separation of human body fluid proteins. 

Phrase: "(1980"

Phrase: ")"

Phrase: "Two-dimensional separation of human body fluid proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0036679:Separation [Pathologic Function]
   744   C0237868:Separation [Social Behavior]
   744   C1881713:SEPARATION [Phenomenon or Process]
Processing 00000000.tx.540: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.541: Chim. 

Phrase: "Chim."
Processing 00000000.tx.542: Acta 100, 121 132[CrossRef][Medline] Bauer, J., Gebicke-Haerter, P. 

Phrase: "Acta 100,"

Phrase: "121 132"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bauer,"

Phrase: "J.,"

Phrase: "Gebicke-Haerter,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.543: J., Ganter, U., Richter, I., and Gerok, W. 

Phrase: "J.,"

Phrase: "Ganter,"

Phrase: "U.,"

Phrase: "Richter,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Gerok,"

Phrase: "W."
Processing 00000000.tx.544: (1988) Astrocytes synthesize and secrete 2-macroglobulin: differences between the regulation of 2-macroglobulin synthesis in rat liver and brain. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "synthesize"

Phrase: "and"

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "2-macroglobulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "differences between the regulation of 2-macroglobulin synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "in rat liver"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.545: Adv. 

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.546: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.547: Med. 

Phrase: "Med."
Processing 00000000.tx.548: Biol.199 205 Koskela, H., Di Sciascio, M. 

Phrase: "Biol.199 205 Koskela,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Di Sciascio,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.549: B., Anderson, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Anderson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.550: D., Andersson, M., Chan, H. 

Phrase: "D."

Phrase: ","

Phrase: "Andersson,"

Phrase: "M."

Phrase: ","

Phrase: "Chan,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.551: K., Gadalla, S., and Katelaris, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gadalla,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Katelaris,"

Phrase: "C."
Processing 00000000.tx.552: (2000) Nasal hyperosmolar challenge with a dry powder of mannitol in patients with allergic rhinitis. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nasal hyperosmolar challenge with a dry powder of mannitol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0027431:Nasal challenge [Diagnostic Procedure]
   742   C0798503:Challenge [Clinical Attribute]
   742   C0805586:Challenge [Health Care Activity]
   742   C3274764:Challenge [Conceptual Entity]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with allergic rhinitis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1334103:allergic rhinitis [Gene or Genome]
  1000   C2607914:Allergic Rhinitis [Disease or Syndrome]
   861   C0035455:Rhinitis [Disease or Syndrome]
   861   C0700624:Allergic [Functional Concept]
Processing 00000000.tx.553: Evidence for epithelial cell involvement. 

Phrase: "Evidence for epithelial cell involvement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.554: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.555: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.556: Allergy 30, 1627 1636[Medline] Lysiak, J. 

Phrase: "Allergy 30,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0002111:Allergy [Biomedical Occupation or Discipline]
   861   C0020517:Allergy [Pathologic Function]
   861   C0489531:allergy [Finding]
   861   C1314973:ALLERGY [Clinical Attribute]
   861   C3539909:Allergy [Disease or Syndrome]
   789 E C0700624:Allergic [Functional Concept]

Phrase: "1627 1636"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lysiak,"

Phrase: "J."
Processing 00000000.tx.557: J., Hussaini, I. 

Phrase: "J.,"

Phrase: "Hussaini,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.558: M., and Gonias, S. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.559: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.560: (1997) 2-Macroglobulin synthesis by the human monocytic cell line THP-1 is differentiation state-dependent. 

Phrase: "(1997"

Phrase: ")"

Phrase: "2-Macroglobulin synthesis by the human monocytic cell line THP-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0220781:synthesis [Biologic Function]
   738   C1883254:Synthesis [Activity]
   718   C2936320:Synthetic Cell [Manufactured Object]

Phrase: "is"

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "state-dependent."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0851827:Dependent [Qualitative Concept]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3148680:State [Geographic Area]
   861   C3244310:dependent [Functional Concept]
Processing 00000000.tx.561: J. 

Phrase: "J."
Processing 00000000.tx.562: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.563: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.564: 67, 492 497[CrossRef][Medline] Kanner, A., Marchi, N., Fazio, V., Mayberg, M. 

Phrase: "67,"

Phrase: "492 497"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kanner,"

Phrase: "A.,"

Phrase: "Marchi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Fazio,"

Phrase: "V.,"

Phrase: "Mayberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.565: R., Koltz, M., Siomin, V., Stevens, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Koltz,"

Phrase: "M."

Phrase: ","

Phrase: "Siomin,"

Phrase: "V.,"

Phrase: "Stevens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551756:Stevens [Population Group]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.566: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.567: G., Masaryk, T. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Masaryk,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.568: J., Apollo, D., Vogelbaum, M., Barnett, G., and Janigro, D. 

Phrase: "J.,"

Phrase: "Apollo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425019:APOLLO [Gene or Genome]
  1000   C2984598:APOLLO [Gene or Genome]

Phrase: "D."

Phrase: ","

Phrase: "Vogelbaum,"

Phrase: "M."

Phrase: ","

Phrase: "Barnett,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Janigro,"

Phrase: "D."
Processing 00000000.tx.569: (2003) Serum S100: a non-invasive marker of blood-brain barrier function and brain lesions. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Serum S100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1441165:S-100 [Immunologic Factor]
   861   C3273837:S100 [Gene or Genome]
   861   C3274824:S100 [Gene or Genome]

Phrase: ":"

Phrase: "a non-invasive marker of blood-brain barrier function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0005516:Marker [Clinical Attribute]

Phrase: "and"

Phrase: "brain lesions."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0221505:brain lesions [Disease or Syndrome]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0221198:lesions [Finding]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.570: Cancer 97, 2806 2813[CrossRef][Medline] Teunissen, C. 

Phrase: "Cancer 97,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0006826:Cancer [Neoplastic Process]
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "2806 2813"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Teunissen,"

Phrase: "C."
Processing 00000000.tx.571: E., de Vente, J., Steinbusch, H. 

Phrase: "E.,"

Phrase: "de Vente,"

Phrase: "J.,"

Phrase: "Steinbusch,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.572: W., and De Bruijn, C. 

Phrase: "W.,"

Phrase: "and"

Phrase: "De Bruijn,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "C."
Processing 00000000.tx.573: (2002) Biochemical markers related to Alzheimers dementia in serum and cerebrospinal fluid. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Biochemical markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206015:Markers, Biochemical [Qualitative Concept]
   861   C0205474:Biochemical [Functional Concept]
   827   C0005516:Marker [Clinical Attribute]

Phrase: "related to Alzheimers dementia"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0002395:alzheimers dementia [Disease or Syndrome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "in serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "cerebrospinal fluid."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
Processing 00000000.tx.574: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.575: Aging 23, 485 508[CrossRef][Medline] Blacker, D., Wilcox, M. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "485 508"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Wilcox,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.576: A., Laird, N. 

Phrase: "A.,"

Phrase: "Laird,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.577: M., Rodes, L., Horvath, S. 

Phrase: "M."

Phrase: ","

Phrase: "Rodes,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Horvath,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.578: M., Go, R. 

Phrase: "M."

Phrase: ","

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.579: C., Perry, R., Watson, B., Jr., Bassett, S. 

Phrase: "C., Perry,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Watson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Bassett,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.580: S., McInnis, M. 

Phrase: "S."

Phrase: ","

Phrase: "McInnis,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.581: G., Albert, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Albert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.582: S., Hyman, B. 

Phrase: "S."

Phrase: ","

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.583: T., and Tanzi, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.584: E. 

Phrase: "E."
Processing 00000000.tx.585: (1998) 2 macroglobulin is genetically associated with Alzheimer disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "2 macroglobulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "genetically"

Phrase: "associated with Alzheimer disease."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.586: Nat. 

Phrase: "Nat."
Processing 00000000.tx.587: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.588: 19, 357 360[CrossRef][Medline] This Article Abstract Full Text (PDF) All Versions of this Article: M200077-MCP200v1 2/4/234 most recent Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Glossary Copyright Permissions Google Scholar Articles by Cucullo, L. 

Phrase: "19,"

Phrase: "357 360"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "M200077-MCP200v1 2/4/234 most recent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0332185:Recent [Temporal Concept]

Phrase: "Submit"

Phrase: "a response Purchase Article View Shopping Cart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441061:Shopping cart [Manufactured Object]
   799   C0179636:Cart [Manufactured Object]
   799   C1824528:CART [Gene or Genome]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "eLetters"

Phrase: "are"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Glossary Copyright Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706852:Article [Intellectual Product]

Phrase: "by Cucullo,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.589: Articles by Janigro, D. 

Phrase: "Articles by Janigro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "D."
Processing 00000000.tx.590: Articles citing this Article PubMed PubMed Citation Articles by Cucullo, L. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Cucullo,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.591: Articles by Janigro, D. 

Phrase: "Articles by Janigro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "D."
Processing 00000000.tx.592: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Journal of Biological Chemistry Journal of Lipid Research Biochemistry and Molecular Biology Education

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "All ASBMB Journals Journal of Biological Chemistry Journal of Lipid Research Biochemistry"

Phrase: "and"

Phrase: "Molecular Biology Education"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0013621:Education [Educational Activity]
   827   C0013622:education [Classification]
   827   C0013658:Education, NOS [Finding]
   827   C0039401:Education [Educational Activity]
   755 E C1555905:Educational [Intellectual Product]
   734   C0026376:Molecular Biology [Biomedical Occupation or Discipline]

